Stockwinners Market Radar for September 04, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:01 EDT Australia's Challenger Limited selects State Street as Custodian - The company states: "State Street announced that it has been selected by Challenger Limited, a publicly listed Australian investment management firm, to provide custody and, through State Street Alpha(R), back-, middle- and front office investment administration services, for a suite of listed and unlisted investment vehicles with A$127B in assets under management. In this new client relationship, State Street will be the custodian and investment administrator for the entire Challenger group, comprising funds management that includes the multi-affiliate platform Fidante, fixed income platform Challenger Investment Management, and Challenger Life, the leading provider of annuity products in the Australian market."

19:50 EDT Allbirds trading halted, news pending

18:47 EDT AeroVironment CEO: We're excited about Q1 and the year - In an interview on CNBC's Mad Money, Wahid Nawabi said AeroVironment had a record quarter in the history of the company. The prospects for growth have "never been better," he added. The company's drones and munition systems simply perform better and are more affordable than the competition, he noted. "We continuously upgrade our systems" he said, and "deliver best in class." He expects to book several more loitering systems contracts in the coming quarters.

17:54 EDT Diamond Offshore CEO Woford sells almost $367K in company shares - The CEO of Diamond Offshore Bernie Wolford disclosed the sale of 26,000 shares of company stock at $14.11 per share on September 3, for a total transaction of $366,860.

17:32 EDT Nvidia CEO sells $27.6M in common stock as part of option exercise - In a regulatory filing, Nvidia disclosed that its CEO Jen Hsun Huang sold 240K shares of common stock on August 30-September 3rd as part of option exercise in a total transaction size of $27.6M.

17:24 EDT Power REIT discloses NYSE listing compliance notice - Power REIT announced that on September 3, 2024, Power REIT received a written notice from the NYSE Regulation of NYSE American LLC stating that the Trust is not in compliance with the continued listing standards of the Exchange because the Trust is below compliance with Section 1003(a)(i) of the NYSE American Company Guide, requiring a stockholders' equity of $2.0 million or more if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years, as a result of the Trust's reported stockholders' equity of $322,626 at June 30, 2024 and losses from continuing operations and/or net losses in two of its three most recent fiscal years ended December 31, 2023. The Trust is also not currently eligible for any exemption in Section 1003(a) of the Company Guide from the stockholders' equity requirements.

17:11 EDT Google uinveils Android 15 features, rolls out to Pixel later in 2024 - Google uinveils Android 15 features including: "Hear detailed audio descriptions of images - now powered by Gemini...TalkBack, Android's screen reader that is designed for people who are blind or have low vision, will now make digital images even more accessible with detailed audio descriptions powered by Gemini models on supported devices. Whether you're looking at online product images, photos in your camera roll, pictures in text messages or images of what's happening on social media, Android's screen reader uses the best of Google AI to bring images to life.Search music you hear in the moment with Circle to Search,,,Instantly search the songs you hear without switching apps. Whether it's a song playing on social media from your phone or music that's playing from speakers near you, just long press the Home button or navigation bar to activate Circle to Search, then tap the music button to identify the track name, artist and even open a YouTube video to explore more - then get right back to what you're doing...And stay tuned for more updates as Android 15 rolls out to more devices later this year including Pixel and other devices." noted Google, in part, in an earlier blog posting. Reference Link

17:06 EDT RTX awarded $405.34M Navy contract modification - RTX was awarded a not-to-exceed $405.34M undefinitized contract modification to a previously awarded firm-fixed-price, cost-plus-fixed-fee, indefinite-delivery/indefinite-quantity contract. This modification adds scope to procure spares for the production and delivery of the F135 propulsion system including spares depot and common for the F-35 global spares pool, and country unique spares in support of the Joint Strike Fighter program for the Air Force, Marine Corps, Navy, non-Department of Defense participants, F-35 Cooperative Program Partners, and Foreign Military Sales customers. Work is expected to be completed in December 2027. No funds will be obligated at the time of award, funds will be obligated on individual orders as they are issued. Naval Air Systems Command is the contracting activity.

17:05 EDT Modular Medical Inc trading resumes

17:03 EDT Huya appoints Raymond Peng Lei as Acting co-CEO and CFO - Huya has appointed Raymond Peng Lei to serve as Acting Co-CEO and CFO, effective September 5. Lei will succeed Ashley Xin Wu as Acting Co-CEO and will jointly assume the duties of CEO of the company with Junhong Huang, Director, Acting Co-CEO and SVP. Upon the appointment of Lei, Wu will continue to serve as VP of Finance. Prior to joining Huya, Lei served as the finance director of Tencent Financial Technology. He first joined Tencent in 2004 and served in various finance roles during his tenure at Tencent of more than 18 years. Previously, Lei worked at PricewaterhouseCoopers for over 10 years.

16:52 EDT Snap CEO Evan Spiegel gives updates, strategy for digital advertising business - Snap (SNAP) CEO Evan Spiegel sent the following note to team members on September 3. The note said in part: "You may be wondering why, with all of the progress we've made in our business over the last year, our share price performance has lagged the overall market. The answer is simple: our advertising business is growing slower than our competitors. The growth of our digital advertising business is one of the most important inputs to our long term revenue potential, and investors are concerned that we aren't growing faster. ...In Q2, even as our upper funnel brand revenue declined by 1%, our lower funnel direct response revenue grew by 16%. Over the years, we have found that lower funnel revenue generated by small- and medium-sized customers is more predictable and stable than upper funnel revenue. ...With active advertisers more than doubling year over year in Q2, we've made a lot of progress, but there is more work to do. As we look ahead to 2025, we need to grow our lower funnel business even faster while simultaneously reaccelerating the growth of our upper funnel business. We're going to do that by changing the way that we go to market, introducing new ad placements powered by automation, and continuing to invest in our machine learning platform to deliver powerful results for our advertising partners. Other companies in the social media space include: Meta Platforms (META), Google (GOOGL, GOOG), and Pinterest (PINS). Reference Link

16:37 EDT Coinbase COO sells $1.69M in common stock - In a regulatory filing, Coinbase disclosed that its COO Emilie Choi sold 9.5K shares of common stock on August 30-September 3rd in a total transaction size of $1.69M.

16:34 EDT Shuttle Pharmaceuticals gets ODD for IPdR to treat brain tumors - Shuttle Pharmaceuticals Holdings provided a corporate update in connection with the filing of its Quarterly Report on Form 10-Q for the second quarter ended June 30 .Shuttle Pharma's recent highlights include the following: Enrollment of patients in the Phase 2 clinical trial of Ropidoxuridine for the treatment of patients with glioblastoma has recently opened following the entry of agreements with two site locations to administer the trial. Ropidoxuridine IPdR is Shuttle Pharma's lead candidate radiation sensitizer for use in combination with RT to treat brain tumors or glioblastoma, a deadly malignancy of the brain with no known cure. Shuttle Pharma expects the Phase 2 clinical trial will be carried out at six site locations, with two sites now ready to start treating patients and all sites anticipated to be treating patients in the coming months.Shuttle Pharma has received Orphan Drug Designation from the FDA, providing potential marketing exclusivity upon first FDA approval for the disease. "We achieved a significant milestone recently with the commencement of our Phase 2 clinical trial of Ropidoxuridine for the treatment of patients with glioblastoma now officially underway and ready to enroll patients," stated Shuttle Pharma's Chairman and CEO, Anatoly Dritschilo, M.D. "To date, we have entered into agreements with two of the planned six site locations with an additional four sites set to come on board in September. The two initial sites have completed site initiation visits and are fully ready to begin treating patients. The results of this Phase 2 clinical trial will determine clinical efficacy of Ropidoxuridine as a radiation sensitizer with the goal of increasing cancer cure rates, prolonging patient survival, and improving the quality of life for patients suffering from glioblastoma."

16:32 EDT Fortive announces management succession plan - At the completion of the spin-off, James A. Lico will retire as President and CEO and as a director. Upon Mr. Lico's retirement, Olumide Soroye, current President and CEO of Fortive's Intelligent Operation Solutions segment, will be appointed as President, CEO, and a director of Fortive. Tami Newcombe, current President and CEO of Fortive's Precision Technologies and Advanced Healthcare Solutions business segments, will assume the role of President and CEO of NewCo in connection with the separation. Fortive also announced that Chuck E. McLaughlin will retire as CFO by the end of the first quarter of 2025.

16:32 EDT Fortive announces separation into two independent public companies - Fortive Corporation announced its intention to pursue a tax-free spin-off of its Precision Technologies segment ("NewCo"). The planned spin-off will create two independent publicly traded companies, each with focused business models and tailored investment and capital allocation strategies. Upon completion of the planned spin-off, Fortive will consist of the portfolio brands currently operating under Fortive's Intelligent Operating Solutions and Advanced Healthcare Solutions business segments. Fortive's market-leading portfolio of technology solutions, with approximately 50% recurring revenue, delivers productivity, safety and reliability value to customers. The company expects to pursue a disciplined and balanced capital allocation strategy, prioritizing M&A that enhances recurring revenue, growth and free cash flow, while remaining balanced between acquisitions and share repurchases. Following the expected completion of the spin-off, NewCo will comprise the same leading brands currently operating under the Precision Technologies segment and will continue to benefit from FBS's ability to drive growth, innovation and value. NewCo will also be poised to capitalize on powerful secular tailwinds across key end markets by leveraging its mission critical technologies in test and measurement, specialty sensors, and aerospace and defense subsystems. With industry-leading margins and cash flow generation, NewCo will be well-positioned to pursue organic growth investments, return cash to shareholders, and seek selective M&A opportunities aligned to its core strategy and value creation levers.

16:31 EDT Voya Financial names Michael Katz CFO - Voya Financial announced that Michael Katz has been named chief financial officer, effective Jan. 1, 2025. He will report to Heather Lavallee, Voya's chief executive officer. Katz, who has been with Voya and its predecessor ING U.S. for more than 20 years, currently serves as executive vice president of Finance and is a member of Voya's Executive Committee. Katz will succeed Don Templin, who has been serving as Voya's CFO since November 2022 and recently made the decision to retire. To ensure a smooth transition of his responsibilities, Templin will serve as a strategic advisor to Voya from Jan. 1, 2025, until his retirement in the first quarter of 2025. "Don's guidance and insight over the past two years have played a critical role in the strategic direction and future growth at Voya," said Lavallee. "During his time at Voya, Don quickly became a trusted advisor to me. I am grateful for his leadership as well as his passion for the business and our people, including the strong team of financial professionals who will continue to support Mike. We thank Don for his continued support and wish him and his family all the best as he embarks on a new chapter in retirement, concluding a truly remarkable career."

16:28 EDT Radiant Logistics acquires Foundation Logistics & Services, terms not disclosed - Radiant Logistics announced it has acquired Foundation Logistics & Services, a Humble, Texas -based, privately held company that provides a full range of specialized transportation and logistics services for companies involved in the exploration, drilling, and production of oil and gas. The company structured the transaction similar to its previous transactions, with a portion of the expected purchase price payable in subsequent periods based on the future performance of the acquired operations. Founded in 2014, Foundation specializes in servicing the oil and gas industry with a focus on the transportation of hazardous materials, including explosives, and urgent oilfield equipment to points around the world. On a post-closing basis, Foundation will continue under the leadership of co-founders Larry Earley and Cindy Jones and continue to operate as Foundation Logistics with the expectation that the company will ultimately transition to operate under the Radiant brand in 2025. Post-closing, both Larry Earley and Cindy Jones will report to Tim O'Brien, SVP and General Manager of Radiant's U.S. forwarding operations.

16:28 EDT Lixiang Education receives noncompliance notification from Nasdaq - Lixiang Education announced that it received a written notice from Nasdaq indicating that the company was not in compliance with Listing Rule 5450, which requires the company to maintain a minimum market value of publicly held shares of $5M for continued listing on the Nasdaq Global Market.

16:25 EDT Liquidity Services selected to sell workover rigs, associated surplus assets - Liquidity Services has been selected by one of the largest oil and gas exploration and production companies in the U.S. to sell more than 30 Cameron, Watson Corsair, Rig Works, and Franks workover rigs and associated surplus assets in West Texas. The rigs are available through a sealed bid event that runs until September 12.

16:21 EDT Topgolf Callaway jumps 12% to $12.03 after announcing Topgolf spin-off

16:19 EDT New Jersey American Water granted new rates by Board of Public Utilities - The New Jersey Board of Public Utilities, BPU, approved a settlement between New Jersey American Water and the N.J. Division of Rate Counsel and BPU Staff for new water and wastewater rates for New Jersey American Water. The approved rates represent a total annualized revenue increase of approximately $79.5 million. The company's rate request was filed on January 19, 2024, and was primarily driven by more than $1.3 billion in infrastructure investment in treatment system and distribution upgrades since its last rate filing.

16:18 EDT Volato announces strategic agreement with flyExclusive - Volato, the largest operator of HondaJet aircraft in the United States, announced an agreement with flyExclusive, Inc., a provider of private jet charter services, to transition the management of its fleet operations to flyExclusive. This move is expected to bring substantial cost savings and provide Volato with the opportunity to focus on its high-growth areas, including aircraft sales and proprietary software. Under the terms of the Aircraft Management Services Agreement, flyExclusive will take over all aspects of operating Volato's fleet, including both revenue and expenses. This transition will allow Volato to reduce its cost base by transferring the operational responsibilities to flyExclusive, which anticipates that the fleet will be profitable under its management. "We are excited about the potential of this agreement, which provides significant benefits to both Volato and flyExclusive," said Matt Liotta, CEO of Volato. "By shifting fleet operations to flyExclusive, we reduce our operational costs while continuing to focus on delivering value through our aircraft sales and expanding our software solutions, such as the Vaunt empty leg program."

16:17 EDT VirnetX receives NYSE non-compliance notification - VirnetX received a notice from the NYSE that the company is not in compliance with the NYSE's Listed Company Manual because its average global market capitalization over a consecutive 30 trading-day period was less than $50M, and, at the same time, its stockholders' equity was less than $50M. The Notice does not have an immediate impact on the listing of the company's common stock and does not affect the company's business operations or its SEC reporting requirements. Within 45 days from receipt of the Notice, the company intends to submit a plan to the NYSE advising it of the definitive action the company has taken, is taking, or plans to take that would bring it into conformity with the continued listing standards. If the NYSE accepts the company's plan, the company's common stock will continue to be listed and traded on the NYSE during the 18-month cure period, subject to the company's compliance with other NYSE continued listing standards and continued periodic review by the NYSE of the company's progress with respect to its plan.

16:16 EDT Equity Residential says same-store revenue growth on track within guidance - Equity Residential provided an update on certain same store operating trends in its business. Same store revenue growth remains on track within the Company's guidance range as described in its second quarter 2024 earnings release published on July 29, 2024. The Company is finishing its primary leasing season with healthy demand and pricing for its apartment units. The Company continues to expect to produce Blended Rate growth of 2.0% to 3.0% for the third quarter of 2024 and Physical Occupancy of 96.2% for the full year 2024.

16:16 EDT Pineapple Energy appoints Andy Childs as interim CFO - Pineapple Energy announced the appointment of Andy Childs as the company's interim CFO. Childs succeeds Eric Ingvaldson who, as previously announced, resigned the position of CFO effective August 30.

16:15 EDT Topgolf Callaway to separate into two independent companies

16:13 EDT XPO, Inc reports August LTL tonnage per day decreased 4.6% YoY - XPO reported certain preliminary LTL segment operating metrics for August 2024. LTL tonnage per day decreased 4.6%, as compared with August 2023, attributable to a year-over-year decrease of 4.5% in shipments per day and a decrease of 0.1% in weight per shipment. Actual results for August 2024 may vary from the preliminary results reported above...Mario Harik, chief executive officer of XPO, said, "In August, we managed our variable costs effectively in a soft demand environment, supporting our outlook for margin expansion. The industry pricing backdrop remains constructive, and we're executing our company-specific initiatives to deliver strong above-market yield growth. Our ongoing service improvements and network investments will further accelerate our results when industry demand rebounds."

16:11 EDT Amcor names Peter Konieczny as CEO - Amcor announced that its Board of Directors has appointed Peter Konieczny as CEO. Konieczny has served as Interim CEO since April 2024. The Board also intends to nominate him as a director for election at the company's Annual Meeting of Shareholders which is expected to be held in November 2024. Konieczny has been a member of the Amcor Global Management Team since 2010 and was appointed Interim CEO in April 2024. Between September 2020 and April 2024, Konieczny served as Chief Commercial Officer, where he oversaw global category and product management, Sustainability, R&D and Procurement while maintaining responsibility for the Amcor Flexibles Latin America business. Prior to Amcor, he had five years of experience in the packaging industry as President of Silgan White Cap, a global organization specializing in metal and plastic closures for the food and beverage industries.

16:08 EDT IN8bio to reduce workforce by 49% - In conjunction with its pipeline prioritization, IN8bio is implementing a workforce reduction of approximately 49% of its current workforce, across all functional areas and at both its New York City and Birmingham, Alabama sites, along with cash compensation reductions implemented across the executive management team and the company's board of directors. IN8bio expects to incur one-time costs of approximately $0.3M in connection with the workforce reduction, of which nearly all are cash expenditures related to severance. Such costs are expected to be incurred in Q3.

16:06 EDT Nvidia says 'have not been subpoeanaed' by Department of Justice - An Nvidia spokesperson told media outlets: "NVIDIA wins on merit, as reflected in our benchmark results and value to customers, and customers can choose whatever solution is best for them. We have inquired with the U.S. Department of Justice and have not been subpoenaed. Nonetheless, we are happy to answer any questions regulators may have about our business."

15:57 EDT Big Tree Cloud Holdings Ltd trading halted, volatility trading pause

15:12 EDT US regulators want to probe Shein and Temu for consumer safety - U.S. safety regulators from the Consumer Product Safety Commission or CPSC are urging staff of the commission to evaluate ecommerce platforms Shein, Temu, and others to determine how these foreign-owned firms that rely on overseas suppliers meet their obligations under the Consumer Product Safety Act. The statement said in part: " Manufacturers, retailers, importers, and distributors of consumer products all fall within the jurisdiction of CPSC, which is charged with protecting consumers from items that pose an unreasonable risk of injury. This examination will inform the Commission on the legal status of these platforms. To the extent a platform falls outside the Commission's reach, policymakers must understand where gaps exist and how best to address them. Likewise, the Commission must better understand what enforcement challenges exist with respect to foreign third-party sellers. Where agencycompliance staff discover safety violations, we expect CPSC to initiate enforcement actions. Shein and Temu raise specific concerns. We are aware of recent media reports that deadly baby and toddler products are easy to find on We are also aware of reporting that thousands of Chinese factories and vendors have joined the supply chain for Shein and Temu, whose popularity has exploded in the U.S. with their offers of inexpensive made-in-China goods,from T-shirts and handbags to electronics and kitchen items."We seek to better understand these firms, particularly their focus on low-value direct-to-consumer,sometimes called de minimis,shipments and the enforcement challenges when firms with little or no U.S. presence distribute consumer products through these platforms." Companies that may be impacted include TJX (TJX), Etsy (ETSY), eBay (EBAY), Macy's (M), Target (TGT) Amazon (AMZN) and Walmart (WMT). Reference Link

15:05 EDT NW Natural Holdings names Brian Fellon as Chief Information Officer - NW Natural Holdings, comprised of NW Natural Gas Company, NW Natural Water, and NW Natural Renewables, has named Brian Fellon as its new vice president, Chief Information Officer/Chief Information Security Officer. Fellon will begin his new role with the company on September 23. Fellon joins NW Natural after spending the last eight years as an executive at Puget Sound Energy in Bellevue, Wash., where he served as director of applications services, AI and data.

14:41 EDT North American rail traffic up 5.2% for the week ending August 31 - The Association of American Railroads, or AAR, reported U.S. rail traffic for the week ending August 31. For this week, total U.S. weekly rail traffic was 516,632 carloads and intermodal units, up 8.4% compared with the same week last year...Total carloads for the week ending August 31 were 233,278 carloads, up 1% compared with the same week in 2023, while U.S. weekly intermodal volume was 283,354 containers and trailers, up 15.3% compared to 2023. Seven of the 10 carload commodity groups posted an increase compared with the same week in 2023. They included grain, up 5,492 carloads, to 20,494; petroleum and petroleum products, up 1,365 carloads, to 11,412; and motor vehicles and parts, up 1,144 carloads, to 17,221. Commodity groups that posted decreases compared with the same week in 2023 were coal, down 5,495 carloads, to 62,624; metallic ores and metals, down 1,487 carloads, to 21,616; and nonmetallic minerals, down 166 carloads, to 32,156... North American rail volume for the week ending August 31 on 9 reporting U.S., Canadian and Mexican railroads totaled 343,419 carloads, up 2.3% compared with the same week last year, and 354,117 intermodal units, up 8.1% compared with last year. Total combined weekly rail traffic in North America was 697,536 carloads and intermodal units, up 5.2%. North American rail volume for the first 35 weeks of 2024 was 23,201,648 carloads and intermodal units, up 2.4% compared with 2023. Publicly traded companies in the space include CN (CNI), CSX (CSX), Canadian Pacific Kansas City (CP), Norfolk Southern (NSC), Union Pacific (UNP), Trinity Industries (TRN), Greenbrier (GBX), Wabtec (WAB), Rail Vision (RVSN) and FreightCar America (RAIL). Reference Link

14:17 EDT VF Corp. says no changes to Q2 guidance excluding Supreme impact - According to a regulatory filing, on September 4, 2024, VF Corporation announced the availability of supplemental investor information related to VF's historical quarterly and annual results for fiscal 2024 and the first quarter of fiscal 2025 that gives effect to the pending sale of the Supreme brand business in accordance with generally accepted accounting principles in the U.S. and on an adjusted basis. VF believes this provides investors with useful supplemental financial information regarding VF's underlying business trends and the performance of VF's ongoing operations, in accordance with GAAP and on an adjusted basis, post the closing of the pending sale of Supreme. Excluding the impact from Supreme in fiscal 2025, there are no changes to VF's expectations for Q2'FY25 as provided on its Q1'FY25 earnings call on August 6, 2024. All comparisons to the prior year exclude Supreme from both years. The rate of revenue decline in Q2 is expected to improve modestly relative to Q1. Gross margin is expected to be up slightly in Q2 relative to last year. SG&A expenses in Q2 are expected to be slightly up versus the prior year period, which excluding Supreme, are expected to increase in the range of $25 million to $35 million, up 2% to 3% versus the prior year. This combined with the aforementioned revenue decline is expected to result in a higher rate of deleverage in Q2 relative to the prior quarter.

13:54 EDT U.S. Steel falls 18% after report that U.S. plans to block Nippon takeover - Shares of U.S. Steel are down $6.34, or 18%, to $29.26 following The Washington Post's report.

13:48 EDT US Steel trading resumes

13:40 EDT Cognyte shareholders re-elected both of company's nominees to board - Cognyte Software announced the vote results of the company's Fiscal Year 2025 Annual Meeting of Shareholders, at which it says shareholders re-elected both the company's nominees, Chairman Earl Shanks and CEO Elad Sharon, to the Cognyte board of directors. "Both nominees received support from a significant majority of the shares voted at the Annual Meeting. Shareholders also supported the proposal to approve the amendments to Cognyte's CEO compensation plan. As a first step towards enhancing disclosures, the Company will report the results of the Fiscal Year 2025 Annual Meeting, as well as the Annual Meetings for the 2024 and 2023 fiscal years, on a Form 6-K that will be filed with the U.S. Securities and Exchange Commission," the company said. Cognyte additionally issued the following statement: "We want to thank our shareholders for their engagement and attention to this Annual Meeting. We appreciate the time shareholders took to understand the issues and cast informed votes, and we learned a lot from their feedback and perspectives. We look forward to continuing our constructive engagement with shareholders as we work diligently on their behalf. We know that we have more work to do, and we are committed to taking further steps over the coming months to augment the composition of our Board and provide additional disclosures. We are confident that these actions will support our continued progress and momentum and help drive sustainable, profitable growth and value for shareholders. "

13:37 EDT Sandy Spring jumps 2% to $31.36 after Bloomberg report on possible sale

13:30 EDT Frontier Communications trading halted, volatility trading pause

13:23 EDT Humana says departing 13 Medicare Advantage markets - Previewing its Medicare Advantage strategy for 2025 at the Wells Fargo Healthcare Conference on Wednesday, Humana said it has decided to quit 13 counties where performance has been unsatisfactory and "unprofitable." "The exit itself is positive in the sense those plans were not contributing," the company says.

13:14 EDT BioMarin sees mid-teen growth rate through 2034, to cut $500M in costs - BioMarin Pharmaceutical said it hosted an investor day earlier where it provided an overview of the company's new corporate strategy "to deliver sustained value creation and introduced longer-term Total Revenue and Non-GAAP Operating Margin guidance." The company's strategy is "now built around three business units, Enzyme Therapies, Skeletal Conditions and Roctavian, designed to support the focus on sustainable growth." The updated corporate strategy also includes the implementation of a $500M cost transformation program that will contribute to Non-GAAP operating margin targets set for 2026 and beyond, BioMarin added. The company also highlighted its innovation strategy that supports its pipeline, including 11 anticipated product launches by 2034 and two by 2027. "The company highlighted its strategy for optimizing its growing and durable Enzyme Therapies business unit, as well as its plan for sustainable leadership across multiple Skeletal Conditions, building on the strength of Voxzogo for the treatment of achondroplasia. The combined business units are expected to drive a targeted mid-teen Compounded Annual Growth Rate through 2034," it added.

12:54 EDT Honda reports August U.S. sales up 25% y/y to 139,950 units - American Honda sales totalled 139,950 units in August, up 25% compared to last year, led by strong passenger car sales, best-ever August light truck sales and an all-time record sales month for electrified models, the company said in a statement. The Honda brand continued its strong sales momentum, topping 127,900 units in August and posting the 7th straight month above 100,000 units, the automaker said.

12:43 EDT EHang 'unequivocally denies' unfounded rumors of link to Chris Hu investigation - EHang Holdings "strongly refuted recent unfounded rumors circulating in retail investor communities," the company stated in a press release. EHang stated: "These baseless allegations have no foundation in truth and have unfairly impacted the Company's stock price. The rumor falsely claims that EHang is related to an investigation on Chris Hu by the U.S. government. EHang unequivocally denies this. The Company's management team, including Huazhi Hu, EHang's Founder, Chairman and CEO, has no relatives or any personal connections involved in the incident mentioned in the rumors, and any suggestion otherwise is completely fabricated. EHang categorically denies any involvement in activities that could harm its reputation or standing with regulatory bodies. EHang has always maintained the highest standards of transparency and compliance in all its operations to ensure that it meets legal and ethical obligations in both China and the U.S. The Company remains focused on its mission to develop and commercialize cutting-edge autonomous aerial vehicle technology. It will continue working diligently to bring innovative solutions to market and drive long-term value for its shareholders. EHang urges investors and the public to rely on official communications from the Company for accurate and up-to-date information. The Company will reserve the right to take appropriate legal action against those who propagate false and misleading information to protect its reputation and the interests of its shareholders."

12:31 EDT Myriad Genetics stops GeneSight study over 'significant disparities' - Myriad Genetics disclosed this morning that as part two a GeneSight, which was designed to analyze the hospital resource utilization and costs of a group of patients who had received GeneSight testing compared to a matched control group of patients who had not received GeneSight testing, has been discontinued. Myriad stated in a regulatory filing: "After the best-matched non-GeneSight control group was identified using the available data, the Company identified significant disparities between the GeneSight patient group and this non-GeneSight control group in baseline hospital resource utilization and costs. The Company believes such disparities indicated that this non-GeneSight control group was not a viable control for part two of the study. As a result, the Company concluded that any data comparing the GeneSight patient group against this non-GeneSight control group were not reliable. Therefore, the Company has determined to discontinue the analysis for this part of the study," Shares of Myriad Genetics are down 9% to $25.00 in midday trading.

12:24 EDT Celsius Holdings: PepsiCo sales this quarter down $120M vs. last year - At the Barclays 17th Annual Global Consumer Staples Conference, Celsius Holdings (CELH) said that despite scanner data up 10% this quarter and depletions running 10%, Pepsi (PEP) sales this quarter are down $120M from last year.

12:21 EDT Vertical Aerospace drops 8% to 75c after Bloomberg report on funding

12:01 EDT Toyota, STAX Engineering enter five-year emissions capture, control deal - STAX Engineering has closed a five-year deal with Toyota Motor North America, Inc. to service all vessels visiting the Toyota Berth in the Port of Long Beach. Beginning in 2025 to coincide with new California Air Resources Board standards, STAX will become the first and only emissions control provider to service roll-on/roll-off vessels in the state of California. The Toyota Long Beach Vehicle Distribution Center imports about 200,000 vehicles each year on ro-ro vessels. STAX's patented, flexible exhaust capture system easily attaches to all vessel classes without modification to remove 99% of emitted particulate matter and 95% of emitted oxides of nitrogen. Over the lifetime of this new agreement with Toyota, STAX estimated the service will account for approximately 3,700 hours and more than 47 tons of emissions controlled.

12:01 EDT Inspire Medical rises 10.0% - Inspire Medical is up 10.0%, or $17.70 to $194.78.

12:00 EDT J.Jill falls -11.4% - J.Jill is down -11.4%, or -$3.68 to $28.56.

12:00 EDT Core & Main falls -14.0% - Core & Main is down -14.0%, or -$6.54 to $40.26.

11:36 EDT Tenon Medical announces 1-for-8 reverse stock split - Tenon Medical announced, a 1:8 reverse stock split of the Company's issued and outstanding common stock. The reverse stock split will become effective at 12:01, Eastern Time, on September 6, 2024, prior to the commencement of trading on the Nasdaq Capital Market. As of that time, each 8 shares of issued and outstanding common stock will be converted into one share of common stock. The Company's common stock is expected to commence trading on a split-adjusted basis when the markets open on September 6, 2024, under the existing trading symbol "TNON." The new CUSIP number for the Company's common stock following the reverse stock split will be 88066N303. At the special meeting held on December 21, 2023, the Company's stockholders approved the reverse stock split. The primary goal of the reverse stock split is to increase the per share market price of the Company's common stock to meet the minimum $1.00 average closing price requirement for continued listing on the Nasdaq Capital Market.

11:24 EDT Kanen Wealth Management calls for sale of U.S. Global Investors - In a letter to GROW directors, Kanen Wealth Management said, in part, "Kanen Wealth Management is one of the largest shareholders of U.S. Global Investors, owning over 450K shares, representing 3.3% of the Company's stock. At the core of our thesis, we believe that the Company's current share price is significantly below its intrinsic value and that investments, real estate, and cash alone are worth more than the market cap. Additionally, we believe its asset management business, with ~$11m in recurring fees, is worth $2.75/share. We are deeply concerned that the board has shown little interest in creating value for outside shareholders by creating policies that funnel an exorbitant amount of money to Mr. Holmes and insiders. In our opinion, Holmes is incentivized to gamble shareholder money to earn larger bonuses for himself. Despite Frank Holmes' reputation as a sophisticated finance expert, GROW continues to trade at a significant discount to its liquidation value. The growing pattern of late filings, accounting restatements, and stock price underperformance suggests the company is not fit for public markets. We remind investors that management rejected a buyout offer two years ago that represents an approximate 100% premium to today's stock price...We believe GROW's stock trades at a significant discount to its liquidation value due to questionable corporate governance and incentives that enrich insiders at the expense of outside shareholders. Given our understanding of the Company's assets and recurring fee income, we believe that a sale of the Company, if undertaken, could generate meaningful and certain value creation for equity investors: GROW Assets: When including $28.5m in cash; $5.2m of HIVE debenture; $11.5m in mutual fund investments; and their estimated ~$6.0m of real estate value, we believe GROW's assets are worth $51.0m, or $3.70/share. Asset Management Business: In addition to our balance sheet, the investment management business generates ~$11 million in recurring fee income. Based on our conversations with industry participants, we believe a strategic would pay 3-4x fee income, which could equate to $2.75/share. If the Board pursues a sale, we believe shares would be worth between $6.0-7.0/share, which represents a 130-175% upside from the current stock price. Because the equity trades below the $51m of tangible assets, the board should immediately authorize a tender up to $3.60 per share which in effect equals the cash, investments, and real estate. The fact that the board doesn't recognize buying $1.00 of assets for $0.70 demonstrates they lack the skillset to serve as directors ($36m market cap with $51m of liquid and tangible assets). It's been over two years since Mr. Holmes dismissed a $5.30 buyout offer as 'insufficient.' We believe such an offer or better is still on the table. If the Board pursues a sale, we believe GROW's equity would be worth 2-3x more than its current stock price implies. Mr. Holmes, it is time to end the public embarrassment that U.S. Global Investors has become. We urge you to run a proper sales process and finally create value for shareholders. What are we waiting for, Director/ Chairman Jerry Rubinstein's 90th birthday?"

10:50 EDT AT&T awarded 10-year contract to provide U.S. DHS with GETS, WPS - AT&T was recently awarded a 10-year contract to provide the U.S. Department of Homeland Security, DHS, with Government Emergency Telecommunications Service, GETS, and Wireless Priority Service, WPS. The contract, initially awarded in March 2024 and valued at $146 million, was expanded in August to extend these services into next generation 5G networks. This contract is the latest in a more than 30-year relationship between AT&T and DHS. DHS's Cybersecurity & Infrastructure Security Agency, CISA, will provide mission-critical communications services that support the agency's national security and emergency preparedness mission.

10:47 EDT Centene's Iowa Total Care awarded statewide Medicaid contract - Centene's Iowa Total Care has been selected by the Iowa Department of Health and Human Services to continue providing Medicaid managed care services under the Iowa Health Link program. The Iowa Health Link program administers Iowa Medicaid, the Iowa Health and Wellness Plan and Healthy and Well Kids in Iowa, to eligible adults, children and pregnant women statewide. The four-year contract is expected to begin July 1, 2025, with a possible two-year extension. Iowa Total Care will continue to provide coordinated physical, behavioral and long-term care to more than 218,600 Iowa Medicaid, Iowa Health and Wellness Plan and Hawki members across 99 counties. Under the new contract, Iowa Total Care will expand the breadth of its home and community-based services while continuing to provide its adult, child and long-term support and services members with integrated care. Iowa Total Care is one of three managed care organizations to provide services.

10:37 EDT Seagate says working with cloud partner to get qualification into cloud segment - Says making "good progress," but product is progressing well and timing could extend into next quarter.

10:30 EDT BioMarin trading halted, news pending

10:08 EDT Select Medical to acquire Valir Rehabilitation Hospital, terms not disclosed - Select Medical announced the signing of a definitive agreement to purchase Valir Rehabilitation Hospital, a 50-bed inpatient rehabilitation facility in Oklahoma City, from Valir Health. Financial terms of the deal were not disclosed. Select Medical also owns and operates Select Specialty Hospital - Oklahoma City, a critical illness recovery hospital, in the market as well as 29 Select Physical Therapy outpatient centers throughout the state, including two in Oklahoma City.

10:06 EDT Mazda North American Operations reports August sales up 36.7% to 41,259 vehicles - Mazda North American Operations reported total August sales of 41,259 vehicles, an increase of 36.7% compared to August 2023. With 28 selling days in August, compared to 27 the year prior, the company posted an increase of 31.9% on a Daily Selling Rate, or DSR, basis.

10:00 EDT Asana falls -12.3% - Asana is down -12.3%, or -$1.64 to $11.65.

10:00 EDT REV Group falls -17.2% - REV Group is down -17.2%, or -$5.20 to $25.01.

10:00 EDT Autohome rises 7.1% - Autohome is up 7.1%, or $1.76 to $26.54.

09:55 EDT QMMM Holdings Ltd trading resumes

09:48 EDT Core & Main falls -13.7% - Core & Main is down -13.7%, or -$6.40 to $40.40.

09:48 EDT Asana falls -13.8% - Asana is down -13.8%, or -$1.84 to $11.45.

09:47 EDT Autohome rises 4.7% - Autohome is up 4.7%, or $1.16 to $25.93.

09:47 EDT Torrid rises 13.5% - Torrid is up 13.5%, or 83c to $6.97.

09:41 EDT Knightscope announces three new contracts for ECDs - Knightscope announces three new contracts for its Emergency Communication Devices. Knightscope Authorized Partner, Colonial Electric - an electrical contractor serving the Northeast - sold 4 K1 Blue Light Towers to a customer in New Jersey, and universities in California and Texas - both existing clients - elected to expand their existing contracts to include other long-term ECD services provided by Knightscope.

09:36 EDT Volaris reports August ASM capacity down 15.1% y/y - In August 2024, Volaris' ASM capacity decreased by 15.1% year-over-year due to the accelerated Pratt & Whitney engine inspections and the resulting aircraft groundings. Volaris transported 2.6 million passengers during the month at a load factor of 87.0%, flat against last year's levels. RPMs for the month decreased by 15.3%, with Mexican domestic RPMs down by 22.0%, while international RPMs were effectively flat. Enrique Beltranena, Volaris' President and CEO said: "Our strategic fleet mitigation plan is on track and continues to deliver favorable outcomes. We have met our goals since the engine inspections began, and we are managing the situation with almost 30% of our fleet on the ground. We reaffirm our annual capacity guidance, which indicates an approximate 14% reduction. Volaris concluded the summer high season with a very solid operational performance and strong demand, which drove high load factors. Please note that comparable load factor figures from August through December of last year already include the consolidation of flights driven by the first round of accelerated P&W engine inspections."

09:31 EDT Blade Air Mobility enters partnership with Qatar Airways - Blade Air Mobility announces its interline partnership with leading global airline, Qatar Airways. This partnership enables Qatar Airways passengers to travel to or from Monaco on a single ticket, seamlessly connecting from their commercial airline to a BLADE helicopter that will fly them into the heart of Monaco. Upon landing at the Monte Carlo heliport, a BLADE limousine service will drive them to their hotel/local destination. In addition to Qatar Airways and BLADE's obsession with exceptional passenger experience, they share a passion for Formula One. Qatar Airways is the Global Partner and Official Airline of Formula 1 and BLADE flies more passengers to the Monaco Grand Prix than to any other event worldwide.

09:26 EDT Hepion, Pharma Two B file registration statement for proposed merger - Pharma Two B and Hepion Pharmaceuticals announced the filing of a registration statement of Pharma Two B on Form F-4 with the U.S. Securities and Exchange Commission. The Registration Statement contains a proxy statement/prospectus in connection with the proposed merger transaction pursuant to the definitive agreement entered into between Pharma Two B and Hepion. While the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about Pharma Two B and Hepion and the Proposed Transaction. As announced on July 22, 2024, Pharma Two B intends to become a publicly traded company on Nasdaq through a merger transaction with Hepion. The Proposed Transaction, which has been approved by the respective boards of directors of Pharma Two B and Hepion, is expected to close in the fourth quarter of 2024 and remains subject to approval by both Pharma Two B and Hepion's respective stockholders, regulatory approval, listing of Pharma Two B's ordinary shares on Nasdaq under the ticker symbol "PHTB" and other customary closing conditions. Upon the anticipated closing of the Proposed Transaction, the combined company will operate under the "Pharma Two B" name.

09:18 EDT Thumzup to promote platform at Main Street Block Party, Day of the Dog Festival - Thumzup Media announced its participation in the Main Street Block Party and Day of the Dog Festival, taking place on Saturday, September 7, 2024. Thumzup will host a booth at the event from 12:00 PM to 7:00 PM PT, promoting its proprietary app that allows users to earn cash for their social media posts. Attendees at the Main Street Block Party and Day of the Dog Festival, the nation's largest pet festival, will have the opportunity to earn $20 by posting about their experience at the event through the Thumzup app. Additionally, they can earn up to $110 more by posting about their visits to participating Main St. businesses, including Dolcenero Gelato, The Bike Shop Santa Monica, Ubatuba Acai, Ashland Hill, Juneshine, Beyond O2, Jinya Ramen, VCA of Santa Monica, Rabano, Jameson's Pub, and the Pump Station.

09:12 EDT Critical Metals commences drilling at Tanbreez rare earth deposit - Critical Metals announced the launch of a diamond drilling program at the Tanbreez Greenland Rare Earth Mine. The drilling program consists of 14 holes with a total cumulative length of up to 2,200 m and will evaluate the resources contained in the mine and the mine's projected lifespan. The drilling program is expected to last approx. 30 days subject to the appropriate weather conditions and site accessibility. "The Tanbreez project offers immense potential for reducing western countries' reliance on China for critical materials needed to support the transition to clean energy and defense applications, thereby bolstering national security," said Tony Sage, CEO. "We look forward to the results of this drilling program as we continue to advance our development strategy for this foundational rare earth asset."

09:09 EDT Applied DNA Sciences receives subcontract award from LRQA - Applied DNA Sciences announced the receipt of a subcontract award from LRQA following a competitive tender for a pilot isotopic testing program. Under the terms of the subcontract, Applied DNA, together with its traceability partner, Isotech, will employ CertainT to conduct isotopic testing and analysis to support cotton traceability in Pakistan. Financial terms of the subcontract were not disclosed. CertainT is Applied DNA's textiles traceability platform that uses forensic, multiple-proof-point evidence to enable source and authenticity verification of materials and products at any point as they are transformed through global supply chains. LRQA is a leading global assurance company that brings together decades of unrivaled expertise in assessment, advisory, inspection, and cybersecurity services. The subcontract with Applied DNA was issued in support of the Global Trace Protocol project, a U.S. Department of Labor-funded initiative implemented by LRQA that is designed to reduce child and forced labor in global supply chains through traceability. The Project engages with trace experts, global brands, Pakistan's cotton sector, and worker organizations to design, implement, and assess the pilot trace tool to improve its future application and develop publicly available commodity-agnostic trace resources for enhanced due diligence.

09:06 EDT JetBlue teams with UBS Arena & the New York Islanders - JetBlue (JBLU)a nnounced a new multi-year partnership with UBS Arena (UBS) and the New York Islanders as the Official Domestic Airline Partner. As New York's Hometown Airline JetBlue is proud to align with an award-winning arena and sports team that shares its customer-centric approach to partnerships and enhancements as the airline continues to underscore its commitment to its loyal TrueBlue and TrueBlue Mosaic customers. "JetBlue is excited to lace up with the New York Islanders and UBS Arena for the ultimate New York power play as the Official Domestic Airline Partner," said Marty St. George, president of JetBlue. "With new JetBlue service from Long Island MacArthur Airport ISP launching next month, we're excited to become an even bigger part of the Long Island community, home of some of our most loyal customers."

09:06 EDT Intapp announces Alpaca Real Estate is live on Intapp DealCloud - Intapp announced that Alpaca Real Estate is live on Intapp DealCloud. The New York City-based firm is using DealCloud to improve data management and drive better trend analysis and decision-making. "As a thesis-driven real estate firm, we know the markets and property types we want to invest in," said Peter Weiss, Co-Founder and Managing Partner at Alpaca Real Estate. "Alpaca Real Estate drives alpha through relative value, focusing on opportunities that present a better market positioning and growth trajectory compared to similar assets."

09:05 EDT U.S. Steel employees to rally in support of Nippon Steel transaction - The company said, "Employees of United States Steel Corporation (X) today will host a rally at the U. S. Steel Tower in Pittsburgh in support of the Nippon Steel (NPSCY) transaction. Employees will call on elected officials in Pennsylvania and across the nation to recognize the significant merits of the transaction for U. S. Steel employees, communities, customers, and American steelmaking."

09:04 EDT AmpliTech Group's AGTGSS division to participate at key trade shows - AmpliTech Group announces the company's participation at two key trade shows domestically and abroad to be held at Las Vegas and Barcelona during the months of October 2024 and March 2025 respectively. "After our significant milestone of unveiling our comprehensive Private 5G End-to-End Solutions to the 5G market, it is critical now we embark on a full business development mode and actively participate at 5G industry events" said Fawad Maqbool, CEO/CTO at AmpliTech Group. "We are fully committed to our growth strategy and will actively participate to make it happen. Our solution empowers businesses and communities with the capability to deploy robust, high-speed 5G networks tailored to their specific needs, whether for industrial applications, residential connectivity, or smart city and smart hub initiatives. The era of true 5G connectivity from tower to home is here!" Furthermore, Mr. Maqbool stated, "Our Private 5G product suite can be sold as stand-alone products, which we soon expect to have our first order for, and as part of a comprehensive end-to-end solution program which includes products and services bundled together, being flexible this way, enhances our chances of 5G customers to take our products, experience their performance and put our brand name out there and start being recognized as premiere supplier of 5G solutions".

09:03 EDT GoPro announces two new cameras - GoPro announced two new GoPro cameras: the top-of-the-line $399 HERO13 Black with its HB-Series Lenses, and the smallest, simplest 4K camera, the $199 HERO. Each camera offers unique new features that build upon GoPro-patented, customer-favorite technologies.

09:02 EDT Abbott initiates TRANSCEND study - Abbott announced it has initiated a pivotal clinical trial, called the TRANSCEND study, to evaluate the use of the company's deep brain stimulation system to manage treatment-resistant depression, a form of major depressive disorder. The U.S. FDA granted Abbott Breakthrough Device designation to explore use of DBS for TRD under its Breakthrough Devices Program, which expedites the review of innovative technologies that can improve the lives of people with life-threatening or irreversibly debilitating diseases or conditions.

08:51 EDT Ciena says to provide detailed FY25 guidance in December - Notes that FY24 to be transition year.

08:48 EDT NeoVolta secures $5M line of credit - NeoVolta announced the securing of a $5M Line of Credit from National Energy Modelers. This strategic financial arrangement is a significant milestone for NeoVolta, as it bolsters the company's working capital while preserving shareholder equity. The LOC is a pure debt financing agreement with no equity component. This allows NeoVolta to advance its short-term objectives and capitalize on emerging opportunities in the residential energy sector without the risk of equity dilution for its shareholders. Importantly, pursuant to the LOC NeoVolta agreed not to utilize its Form S-3 registration statement. This means that NeoVolta cannot issue shares under the 'shelf' registration statement without the lender's consent, effectively addressing recent investor concerns about potential dilution arising from the registration statement. The LOC will provide NeoVolta with the necessary capital to advance its strategic initiatives, ensuring that the company can continue to innovate and lead in the rapidly evolving solar storage market.

08:47 EDT LQR House announces 540% year-over-year revenue growth in August - LQR House announced a significant 540% year-over-year increase in revenue for the month of August 2024, compared to the same period in 2023. In August 2023, LQR House reported revenues of $38,425.00. Fast forward to August 2024, the Company experienced an impressive revenue surge, reaching $246,005.12. Sean Dollinger, CEO of LQR House, commented, "We believe that the partnerships we've forged have been instrumental in propelling our revenue to new heights. By leveraging influencer-driven content, we've successfully increased traffic to our platform, CWSpirits.com in August 2024 comparing to August 2023. Additionally, we believe that the introduction of even more mainstream inventory has further fueled sales growth. We're particularly excited about the expansion of the SWOL Tequila brand into new markets, and we remain committed to building on this momentum as we continue to scale."

08:45 EDT Ciena 'encouraged' by improving industry dynamics - Comments taken from Q3 earnings conference call.

08:44 EDT Dril-Quip urges stockholders to Vote merger with Innovex - The Dril-Quip, Board of Directors unanimously recommends and urges Dril-Quip stockholders to vote "FOR" the proposed merger with Innovex Downhole Solutions or Innovex, and each of the proposals to be considered at the special meeting on Thursday, September 5.... The merger of Dril-Quip and Innovex is immediately and significantly accretive on all core metrics to Dril-Quip stockholders and offers the following strategic merits: Positions the Company with a scaled and diversified global market presence..."Establishes a curated portfolio of complementary, mission-critical products... Enables key market expansion through cross-selling and accelerated penetration - lower 48, Canada, Saudi Arabia and global offshore ... Unlocks significant and achievable cost synergies of approximately.."

08:43 EDT SeaStar Medical eliminates all long-term debt - SeaStar Medical Holding reports that it has now retired all long-term debt, which will be reflected on its balance sheet for the quarter ending September 30, 2024.

08:42 EDT Netgear teams with Samsung Electronics on interoperability and roaming - Netgear (NTGR) announced a strategic collaboration with Samsung Electronics' System LSI Business (SSNLF) to help create seamless interoperability and roaming between NETGEAR Business WiFi 7 access points and Samsung's WiFi 7 client chipset solution. In environments with multiple mobile devices all needing to get online at any time, one of the biggest issues to solve is WiFi roaming. Stationary devices that connect to one access point all the time don't usually have a problem getting online, but users with cell phones, moving from one floor to another in an office building or from building to building on a campus may experience some lag in connectivity as their phones disconnect from one access point and try to connect to the next. The problem is amplified in an auditorium, for example, where hundreds of users converge in one place and try to connect to the same access point all at once. This pain point, identified by NETGEAR and Samsung as a top priority, is bringing the two companies together to work on a solution.

08:41 EDT Fangdd Network announces updates on substitution listing plan - Fangdd Network Group announced further updates on its substitution listing plan. As previously announced on June 3 and July 31, 2024, the Company intends to terminate its existing American depositary receipts facility and list its Class A ordinary shares for trading on The Nasdaq Stock Market in substitution for the American depositary shares. The Company expects that, upon the effectiveness of the Substitution Listing, its ADSs will cease to be listed on Nasdaq while the Class A ordinary shares represented by the ADSs will trade on Nasdaq under the symbol of "DUO." The Company has appointed VStock Transfer, LLC as its United States transfer agent for the Substitution Listing. To facilitate the Substitution Listing, The Bank of New York Mellon will call for the surrender of all ADSs to be exchanged into the Company's Class A ordinary shares on a mandatory basis. For ADSs held by participants of The Depository Trust Company, the Depositary will instruct the U.S. Transfer Agent to register a transfer of the number of deposited shares represented by those ADSs to DTC for allocation by DTC to the participant accounts entitled to them; and for uncertificated ADSs held by owners other than DTC, the Depositary will instruct the U.S. Transfer Agent to register transfers of the number of deposited shares represented by uncertificated ADSs in the names of the respective owners. The Company anticipates that the Mandatory Exchange will not take effect on September 4, 2024, as initially scheduled. The Company is actively working with DTC, Nasdaq and other related parties to finalize the Mandatory Exchange and will announce the effective date as soon as it becomes available. ADS holders do not need to take any action and the Depositary will not charge ADS holders any fees in connection with the Mandatory Exchange. The Depositary will issue a notice regarding the Mandatory Exchange to supersede its prior notice issued to ADS holders on July 30, 2024. There remains uncertainty regarding whether and when the Company will be able to obtain clearance from Nasdaq to effectuate the Mandatory Exchange and the Substitution Listing. Prior to the exchange date, Nasdaq may suspend the trading of the Company's ADSs until such time as the Mandatory Exchange and the Substitution Listing shall have taken effect or as otherwise determined by Nasdaq.

08:40 EDT Wearable Devices publishes report by extended reality team - Wearable Devices has published its third comprehensive report by its extended reality team. This report reviews the integration of wearable and camera gesture-control technologies and sets a definitive benchmark for the future of gesture-control wearables. The report, titled "Interaction Beyond Boundaries: Integrating Wearable Neural Interfaces and Gesture Recognition Cameras for Enhanced User Experience," establishes that Wearable Devices is in a unique position leveraging both market knowledge and advanced neural technology perspectives. The insights presented in this new report provide an essential requirements framework for any commercially viable and truly useful gesture-control wristband. As such, it sets the bar for the entire wearables market against which all future gesture-control wristbands and rings should be measured. The report also analyzed how the Mudra input wristband can be tailored to provide natural and intuitive input solutions for screenless, limited and rich display face-worn products. For screenless devices, like the Meta Ray-Ban smart glasses, discrete finger movements such as tap, a double-tap, and index or thumb finger movements with wrist orientation can emulate a controller-type input. For monocular displays, used in products such as the Google Glass Edition 2, using flicks - hand swipes and scrolls - for navigation, and tap/double tap gestures to input commands offers clear, distinct directional gestures such as a directional pad, that maximizes accuracy and minimize the likelihood of accidental presses. For mixed reality rich display headsets, the Mudra wrist-worn input solution can offer a full pointing device capability - navigating a cursor using wrist movements and gesturing using tap and drag gestures.

08:39 EDT Worlds Inc. uplists to OTCQB - Worlds uplisted from the OTC Pink Market to the OTCQB Venture Market, effective for trading immediately. Worlds will continue to trade under the ticker symbol "WDDD."

08:37 EDT Outlook Therapeutics announces completion of enrollment in NORSE EIGHT trial - Outlook Therapeutic announced the completion of enrollment for its NORSE EIGHT clinical trial evaluating ONS-5010 in wet AMD patients. NORSE EIGHT is the subject of a Special Protocol Assessment, SPA, agreement with the FDA, and, if successful, is the final anticipated clinical trial required before expected resubmission of the Outlook Therapeutics' Biologics License Application, BLA, for ONS-5010. "We are very pleased to complete this important milestone in our effort to resubmit our BLA for ONS-5010. On behalf of Outlook Therapeutics, I would like to express gratitude to the patients and dedicated teams at the clinical sites, as well as our clinical and regulatory staff, who enrolled this entire patient population in less than 8 months after our SPA agreement from FDA," commented Russell Trenary, President and Chief Executive Officer of Outlook Therapeutics.

08:37 EDT Central Florida hospital implements Daxor BVA-100 blood volume diagnostic - Daxor Corporation announces the expansion of its blood volume analysis capabilities through its ezBVA Lab service. Daxor will partner with the hospital to provide lab processing of its patient tests, providing a rapid 24-hour testing service that is highly efficient for the hospital to implement.

08:36 EDT 3D Systems announces QuickCast Air - 3D Systems announced QuickCast Air, an advanced tool in its investment casting portfolio, designed to maximize material removal from the interior of casting patterns. This enables reduced material consumption, lower pattern costs, faster build times, cleaner burnout processes, and improved draining efficiency. As a result, end-users in industries such as foundries, aerospace & defense, and energy can reliably deliver large, high-precision investment casting patterns at a fraction of the time and cost of traditional tooling and with no limitation on geometric complexity. QuickCast Air is already helping some of the Company's large-volume aerospace customers reduce the material consumption on their patterns by up to 50%. Additionally, customers are seeing a multi-hour reduction in build times.

08:35 EDT OSI Systems gets $5M order to deliver advanced optical sensors - OSI Systems announced that its Optoelectronics and Manufacturing division received an order valued at approximately $5M to deliver advanced optical sensors to a top-tier defense electronics original equipment manufacturer OEM . These high-precision components are designed for integration into complex navigation and guidance systems. OSI Systems' Chairman and Chief Executive Officer, Deepak Chopra, stated, "We are proud to receive this award and contribute to global security with our innovative optical sensor solutions."

08:33 EDT Osisko Gold provides update on Ermitano Mine, Island Gold District - On July 31st, 2024, First Majestic Silver Corp. (AG) announced the discovery of a significant new, vein-hosted gold and silver mineralized system at its Santa Elena property in Sonora, Mexico. This new high-grade discovery, the Navidad vein system, was made at depth adjacent to the Company's 100%-owned and currently producing Ermitano mine. To date, seven drill holes have been completed to test the Navidad discovery; six of these holes intersected significant vein-hosted gold and silver mineralization. The closest drill hole intercept to the Ermitano mine is located approximately 500 m southwest and 750 m below existing mine development. Osisko's 2% NSR royalty on Ermitano would include Navidad, as well as the adjacent Cumobabi property. Island Gold District: Alamos Gold's (AGI) Island Gold District is comprised of the adjacent Island Gold and Magino Mines. On July 23rd, 2024, Alamos reported new results from underground and surface drilling at the Island Gold Mine. Exploration drilling continues to extend high-grade gold mineralization across the Island Gold Deposit, as well as within several hanging-wall and footwall structures. Delineation and definition drilling has defined wide, higher-grade zones within the Island East area. This is expected to drive further growth in high-grade Mineral Reserves and Resources with the year end update. Additionally, high-grade mineralization was intersected in the North Shear and the Webb Lake stock area, highlighting a longer-term, near-mine opportunity as a potential source of additional mill feed for the expanded Magino milling complex. Osisko owns a 1.38-3% NSR royalty on the Island Gold Mine. With the district now fully consolidated, Alamos' expanded and accelerated Phase 3+ mine plan at Island Gold is anticipated to transition a greater proportion of production towards Osisko's 2% and 3% NSR royalty boundaries earlier in the mine plan, as opposed to the mineral inventory covered by Osisko's 1.38% NSR royalty. A small portion of the eastern limit of the Magino pit is covered by the 3% NSR royalty owned by Osisko, with deliveries under the royalty expected from 2030 onwards. The underground exploration potential previously highlighted by former owner Argonaut Gold on this claim is located less than 300 m from the existing Island Gold underground mine infrastructure, a portion of which is covered by Osisko's 3% NSR royalty.

08:31 EDT Trinity Capital provides $50M in capital to LightForce - Trinity Capital announced the commitment of $50M in growth capital to LightForce, makers of the world's first fully personalized 3D printed braces system. LightForce specializes in personalized orthodontics, focusing on the development and production of 3D printed dental brackets.

08:28 EDT Osisko Gold provides update on Windfall Project, CSA Mine - On August 12th, 2024, Osisko Mining (OR) announced that it had entered into a definitive arrangement agreement with Gold Fields Limited (GFI) pursuant to which Gold Fields would consolidate ownership of 100% of the Windfall project through the acquisition of all the issued and outstanding common shares of Osisko Mining at a price of $4.90 per share in an all-cash transaction valued at approximately $2.16 billion. Osisko Mining holds a 50% interest in the high-grade Windfall gold deposit located in Quebec and holds a 50% interest in a large area of claims in the surrounding Urban Barry area and nearby Quevillon area, with the other 50% of Windfall and the large area of claims already owned by Gold Fields. Subject to the satisfaction of all conditions to closing set out in the Arrangement Agreement, it is anticipated that the transaction will be completed in Q4 2024. Osisko owns a 2-3% NSR royalty on the Windfall project and surrounding property. CSA Mine: On July 22nd, 2024, Metals Acquisition Limited (MTAL) announced that, during the second quarter, CSA had achieved record quarterly copper production of 10,864 tonnes under its management, up ~24% quarter-on-quarter, with record monthly copper production in June 2024 of 5,378 tonnes. The record quarter was achieved despite a major planned maintenance shutdown in April, with 1,583 tonnes produced for the month, along with a combined 9,281 tonnes of copper produced over May and June. During the second quarter, the mined grade at CSA averaged 4.2% copper a ~20% increase from the prior quarter as the mine plan shifted to higher grade stopes and dilution control was improved. In addition, on July 30th, 2024, MAC provided a market update on the continuing exploration and resource development at CSA. MAC's underground exploration continued to focus on the down dip and along strike extensions of the QTSN and QTSC deposits, as well as the shallower, up-dip portions of the East and West deposits and QTSS Upper A zone. Drill results reported in the release included 22.1 m at 9.8% Cu, 22.1 m at 7.8% Cu and 24.2 m at 7.8% Cu. These reported results, amongst others, are after the cut-off date for the 2023 Resource and Reserve and will be incorporated in the 2024 Resource and Reserve Estimate update for CSA. Osisko owns a 100% Silver Stream, in addition to a 3.0-4.875% Cu Stream, on the CSA Mine.

08:27 EDT Special Committee of Nordstrom board confirms receipt of going-private proposal - The special committee of the Board of Directors of Nordstrom confirmed receipt of a proposal from Erik and Pete Nordstrom, other members of the Nordstrom family, and El Puerto de Liverpool, to acquire all of the outstanding shares of the company, other than shares held by members of the Nordstrom family and Liverpool, for $23.00 per share in cash. The proposal states that the merger consideration would be financed through a combination of rollover equity and cash commitments by members of the Nordstrom family and Liverpool and $250M in new bank financing, with the existing indebtedness of the company to remain outstanding. The special committee, composed of independent and disinterested directors, was formed in response to interest expressed by Erik and Pete Nordstrom in exploring a possible transaction. The special committee and the other independent directors will carefully review the proposal in consultation with independent financial and legal advisors to determine the course of action that is in the best interests of Nordstrom and all shareholders. No action is required by Nordstrom shareholders at this time. There can be no assurance that the company will pursue this transaction or other strategic outcome, or that a proposed transaction will be approved or consummated. The company does not intend to disclose further developments regarding this matter unless and until further disclosure is determined to be appropriate or necessary.

08:26 EDT Osisko Gold provides update on Upper Beaver, Shaakichiuwaanaan projects - Osisko Gold Royalties provides some select asset updates. Jason Attew, President & CEO of Osisko commented: "Over the past few months, Osisko's asset base provided for some positive developments that have surfaced incremental value for the Company, with more portfolio catalysts expected between now and end-of-year 2024. In the meantime, much of Osisko's short-to-medium-term growth continues to be underpinned by several advanced projects including three shafts currently under construction at Odyssey Underground, the Island Gold District, and Hermosa/Taylor, along with two open pits at, or nearing, the final stages of development at Tocantinzinho and Namdini, respectively." Upper Beaver Project: On July 31st, 2024, Agnico Eagle Mines (AEM) provided an update on its Upper Beaver project located approximately 25 kilometres to the east of the town of Kirkland Lake in Ontario, Canada. A positive internal evaluation was completed for a standalone mine and mill scenario at Upper Beaver. Based on this evaluation, Agnico Eagle believes Upper Beaver has the potential to produce an annual average of approximately 210,000 ounces of gold and 3,600 tonnes of copper, with initial production possible as early as 2030. Over an expected 13-year mine life, total payable gold and copper production is expected to be approximately 2.8 million ounces and 46,300 tonnes, respectively. The mining strategy developed for the Upper Beaver project is to mine the deposit mainly by conventional underground methods, although a small portion will be mined via an open pit. The underground and open pit mines are expected to be developed within the same time frame. Current scenarios contemplate underground access through a main decline ramp as well as a shaft that is 1,220 metres deep. In addition, the project has the potential to unlock significant exploration potential at depth and within satellite deposits in Agnico Eagle's Kirkland Lake camp, including the Upper Canada and Anoki-McBean projects. Agnico Eagle has approved a US$200 million investment over three years to further de-risk the project, with work having already commenced in 2024. Excavation of the ramp and shaft-sinking are expected to start in H2 2025. Osisko's owns a 2% net smelter return royalty on the Upper Beaver project, as well as a 2% NSR royalty that covers most of Agnico's Kirkland Lake regional properties, including Amalgamated Kirkland, Munro, Anoki-McBean, Bidgood, and Upper Canada. Shaakichiuwaanaan Project: On August 21st, 2024, Patriot Battery Metals (PMETF) announced the results from a Preliminary Economic Assessment for its flagship Shaakichiuwaanaan hard-rock lithium project located in the Eeyou Istchee James Bay region of Quebec, Canada. The PEA was based on the CV5 Pegmatite component of the recently announced updated Shaakichiuwaanaan Mineral Resource Estimate, which is the largest known lithium pegmatite Mineral Resource in the Americas and the 8th largest globally. Based on the PEA, the Shaakichiuwaanaan project has the potential to become one of the largest spodumene producers in the world and the largest spodumene producer in the Americas. The PEA incorporates a staged development strategy, with Stage 1 targeting production capacity of ~400 kilotonnes per annum of spodumene concentrate and Stage 2 aimed at expanding the production capacity to ~800 ktpa. The Shaakichiuwaanaan project's mine life is projected at 24 years, based on a total extracted Mineral Resource of 66% of total resources defined at CV5. Based on the results of the PEA, Patriot will now consider advancing the project to the Feasibility Study level, which if progressed is expected to be completed in Q3 2025. Osisko holds a sliding scale NSR royalty of 1.5-3.5% on precious metals, and 2.0% on all other products, including Lithium, at Shaakichiuwaanaan. Osisko estimates that a large majority of the CV5 MRE falls on its 2.0% Lithium NSR royalty area. The PEA includes only the CV5 Spodumene Pegmatite, and therefore does not include any of the other known spodumene pegmatite clusters on the property - CV4, CV8, CV9, CV10, CV12, and CV13; some of which are covered by Osisko's royalty.

08:23 EDT Nordstrom family offers to buy Nordstrom for $23 per share in cash - In a regulatory filing, it was stated: "Erik B. Nordstrom and Peter E. Nordstrom, as fourth generation leaders of the Issuer, regularly monitor and evaluate the Issuer's business, financial condition, operating results and prospects. In February 2024, Erik B. Nordstrom and Peter E. Nordstrom, whose individual and combined beneficial ownership of Common Stock at that time was below 5%, advised the Board of their desire to make a proposal for consideration by the Board and explore potential equity financing for a "going private transaction" involving the acquisition of the outstanding shares of Common Stock of the Issuer. They also agreed to condition any Going Private Transaction on the affirmative vote by a majority of the votes entitled to be voted by unaffiliated stockholders of the Issuer. The Issuer's Board subsequently approved the formation of a Special Committee of certain independent and disinterested directors to review any proposal for a Going Private Transaction... After receiving that approval from the Board on September 3, 2024, on September 3, 2024, the Group delivered a non-binding letter to the Special Committee proposing a transaction whereby the Group, through a newly-formed entity, would acquire by merger, for a purchase price of $23.00 in cash per share, all of the outstanding shares of Common Stock of the Issuer other than the Rollover Shares. The members of the Group who are members of, or are affiliated with, the Nordstrom family have retained Moelis & Company LLC to serve as their financial advisor and Wilmer Cutler Pickering Hale and Dorr LLP as their legal advisor." Reference Link

08:21 EDT Sunshine Biopharma announces publication of coronavirus research results - Sunshine Biopharma announced the publication of new research results in the Journal of Medicinal Chemistry. The published data demonstrate a novel PLpro inhibitor with submicromolar potency and in vivo efficacy in a mouse model of SARS-CoV-2 infection. This peer-reviewed study marks an important milestone for Sunshine Biopharma in its effort to develop an effective treatment for SARS-CoV-2 infection. There are still unmet medical needs to combat SARS-CoV-2 infection. SARS-CoV-2 undergoes mutation at a rapid rate, which leads to the continuous emergence of variants of concern posing a significant threat to public health. In addition, certain populations, such as immunocompromised patients who are susceptible to severe and prolonged infections, may not respond well to current therapies or vaccines. For high-risk patients, blocking early infection at home may prevent disease rapid progression and reduce hospitalization. PLpro is a compelling therapeutic target for developing antiviral compounds against SARS-CoV-2. It is a virus encoded protease essential for viral replication and is responsible for suppression of the human immune system following infection by the virus. The active site of an enzyme is almost always the primary target for drug design. PLpro eluded scientist for many years due to its featureless active site. To address the challenge of PLpro's indistinct active site, we designed and synthesized a noncovalent inhibitor library targeting a vulnerability in PLpro remote from the active site incorporating the "BL2-groove", a key feature discovered by project co-lead, Prof. Rui Xiong of the University of Arizona. One of the 50 compounds, XR8-23, had an enzyme inhibition activity of 0.39 microM and exhibited a broad spectrum of antiviral activity towards at least 4 strains of VOC including WA1/2020, Gamma, Delta, and Omicron. It had over 10-fold of selective accumulation in the lungs than in plasma and exhibited in vivo activity in a mouse-adapted SARS-CoV-2 infection at 10 mg/kg by repeated IV injections.

08:20 EDT Nuburu teams with CDME at Ohio State on blue wavelength lasers in manufacturing - Nuburu announces a partnership with the Center for Design and Manufacturing Excellence CDME at Ohio State University in Columbus, Ohio. The Company has received a purchase order for its advanced BlueScan solution, which includes a BL-250 laser, scanner, and optics. This cutting-edge technology will be installed within a powder bed fusion system at CDME's state-of-the-art development lab. The advantages of blue lasers for enhancing additive manufacturing processes with both powder and wire have been well established. With the introduction of the BL Series, beam quality has improved significantly, facilitating seamless integration of the BL laser into powder bed fusion machines. The installation at CDME will enable direct comparisons with existing techniques, driving innovation and efficiency in the additive manufacturing landscape. Additionally, interested third parties can collaborate with CDME to guide this pioneering research.

08:19 EDT Marathon Digital produced 673 bitcoin in August - "During the month of August, we continued to bring additional hash online and our energized hash rate grew to 35.2 EH/s, an 11% increase over July," said Fred Thiel, MARA's chairman and CEO. "We are proud to have mined our 4,000th block during August. Block wins during the month declined 2% from July while BTC production decreased 3% to 673 BTC. We continue to invest in our mining operations and grow our business, utilizing every available resource and strategy.

08:17 EDT Palo Alto Networks completes acquisition of IBM????s QRadar SaaS assets - Palo Alto Networks (PANW) announced that it has completed the acquisition of IBM's (IBM) QRadar Software as a Service assets. This transaction underscores Palo Alto Networks and IBM's commitment to secure customers with best-in-class threat prevention, addressing ever-expanding attack surfaces with the complete platform approach that is required to simplify security operations. Palo Alto Networks Precision AI-powered Cortex XSIAM platform centralizes data and security operations capabilities that include SIEM, SOAR, ASM and XDR into a single platform to drastically streamline security operations and prevent threats at scale. Together, Palo Alto Networks and IBM, as a preferred managed security services provider, will help global customers across industries seize the opportunity to shift from QRadar to Cortex XSIAM with no-cost migration services through IBM Consulting for eligible customers. In addition, IBM has furthered its internal deployment of Palo Alto Networks security platforms with the deployment of Cortex XSIAM for its own next-gen security operations, and Prisma SASE 3.0 for zero-trust network security to safeguard more than 250,000 of its global workforce. IBM's adoption of these marquee technologies is an example of how customers can benefit from the streamlined operations of products across the Palo Alto Networks portfolio. Further, Palo Alto Networks will deploy IBM solutions, including watsonx AI and data platform, to drive additional AI and automation capabilities.

08:16 EDT Golden Matrix introduces version 2.0 of casino game recommender - Golden Matrix Group announced the launch of Version 2.0 of its AI-powered casino game recommender, developed by its subsidiary, Meridianbet. This update specifically targets the iGaming segment, enhancing personalization and tracking capabilities to improve user engagement, retention, and revenue performance. The V2 recommender now processes an expanded dataset, including player behaviors and demographics, delivering more precise game recommendations that resonate with individual preferences, offering advanced AI-driven insight. Initial data shows significant increases in user interaction and retention, with personalized recommendations driving higher player value and extended playtime.

08:14 EDT Enphase announces solution for expanding legacy NEM systems in California - Enphase Energy announced a solution for expanding legacy net energy metering, NEM, solar energy systems in California without penalty using new Enphase Energy Systems configurations with IQ Microinverters, IQ Batteries, and Enphase Power Control.

08:13 EDT ARS Pharmaceuticals launches pre-ordering services for neffy - ARS Pharmaceuticals announced pre-ordering services for neffy, ensuring swift access upon availability, expected in late September. Recently, the U.S. Food and Drug Administration, FDA, approved neffy for the treatment of Type I Allergic Reactions, including anaphylaxis, in adults and children who weigh greater than or equal to30 kg.

08:09 EDT ADNOC to acquire 35% stake in Exxon Mobil facility in Texas - Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and chairman of the Abu Dhabi Executive Council, has witnessed the signing of an agreement that ADNOC will acquire a 35% equity stake in Exxon Mobil's proposed low-carbon hydrogen and ammonia production facility in Baytown, Texas. The agreement represents a significant investment in the United States' energy production and the global energy transition. It will help reduce greenhouse gas emissions across hard-to-decarbonize sectors, including industry, energy and transportation, meet rising demand for lower-carbon fuels, and accelerate a net-zero future. Contingent on supportive government policy and necessary regulatory permits, the facility is expected to be the world's largest of its kind upon startup, capable of producing up to 1B cubic feet daily of low-carbon hydrogen, which is virtually carbon-free with approximately 98% of carbon dioxide removed and more than 1M tons of low-carbon ammonia per year. A final investment decision is expected in 2025 with anticipated startup in 2029. The facility will leverage advanced carbon capture and storage technologies to reduce emissions associated with hydrogen production.

08:09 EDT Advantage Solutions unveils comprehensive rebrand - Advantage Solutions unveiled a new brand identity inspired by its dynamic workforce and designed to reflect its transition to a unified retail solutions company positioned at the center of brands, retailers and shoppers. Advantage, a provider of sales and omnichannel marketing solutions to consumer goods manufacturers and retailers, launched its new visual identity and messaging framework, as well as a teaser website, YourADV.com, with the full and expanded web experience slated to debut within weeks. "Our rebrand is more than a new look; it's a testament to our commitment to delivering collective solutions to brands and retailers in a rapidly evolving marketplace," said Dave Peacock, CEO of Advantage Solutions. "We are now able to go to market as a cohesive enterprise, leveraging the combined capabilities of more than 70,000 teammates to generate demand for more than 4,000 clients and more than 100,000 retail locations in North America." Advantage has simplified its business by re-segmenting its operations into three business units, collaborating to deliver the five core differentiated solutions it provides to retailers and CPG companies. Aligning capabilities under a single enterprise makes it easier for clients to access the full spectrum of the company's expertise and allows for the delivery of customized solutions that help all stakeholders succeed - whether it is enhancing sales, tapping into deep supplier relationships for product innovation, leveraging omnichannel marketing expertise across physical and digital spaces or building out retail spaces. The five solution areas include: Insights and Sales Growth: Using advanced proprietary data and real-time intel to uncover new opportunities and propel business expansion. Product, Aisle and Shelf Reinvention: Transforming whitespaces into thriving marketplaces to bring brands to life and optimize store layouts. Brand and Retail Execution: Ensuring a seamless shopping experience, from warehouse to physical and digital shelves and into people's hands and homes. Omnicommerce and Experiential Marketing: Creating buzz, bold moments and meaningful experiences in-store and online, including sampling, demonstrations and retail media, to help brands break through, win hearts and fill carts. Private Brand Solutions: Offering end-to-end services driving private brand strategy and development for retailers, while delivering quality and value for shoppers.

08:08 EDT Worksport announces release of new tonneau cover applications - Worksport announce the release of new tonneau cover applications. These covers are available for various models including but not limited to those from General Motors, Ford, and Hyundai, thereby expanding availability and market reach. This initiative showcases the expertise of Worksport's engineering team and aligns with the Company's growth strategy, which reflects its commitment to pursuing market opportunities and establishing a foundation for long-term success and industry leadership.

08:07 EDT Duos Technologies Group launches first edge data center - Duos Technologies Group announces the launch of its first Edge Data Center, EDC, at the Region 16 Education Service Center in Amarillo, Texas. This strategic partnership marks a significant milestone in bringing high-speed connectivity and advanced technological solutions to classrooms throughout the Texas Panhandle. The new EDC will provide vital infrastructure to support student learning by delivering reliable and high-speed internet access. This will enable innovative educational tools and resources, ensuring that students have access to the same quality of education as those in urban centers.

08:06 EDT Windtree Therapeutics completes enrollment of Phase 2b study of istaroxime - Windtree Therapeutics announced it has successfully completed enrollment in its SEISMiC Extension Phase 2b study of istaroxime in early cardiogenic shock caused by heart failure. The study is evaluating the ability of istaroxime to improve heart function and low blood pressure in the setting of early cardiogenic shock due to heart failure. The Company is looking to extend the positive results on these parameters as observed in the Company's first SEISMiC Phase 2 clinical study that was previously reported. In addition, the Company hopes that the study results will substantiate the encouraging observations from the Company's Phase 2 clinical study, indicating istaroxime has a favorable renal profile and does not increase cardiac arrhythmias.

08:05 EDT ALX Oncology announces first patients dosed with evorpacept, sarclisa - ALX Oncology (ALXO) announced the first patients have been dosed in an arm of the randomized UMBRELLA phase 1/2 clinical study partnered with Sanofi (SNY) that is evaluating evorpacept in combination with SARCLISA. Evorpacept is ALX Oncology's investigational CD47-blocking therapeutic that uniquely combines a high-affinity CD47-binding domain with an inactivated Fc domain and SARCLISA is Sanofi's approved CD38 monoclonal antibody in patients with relapsed or refractory multiple myeloma.

08:04 EDT Epam Systems to acquire Neoris, terms not disclosed - Epam Systems (EPAM) announced that it has entered into an agreement to acquire Neoris, a Miami-headquartered global advanced technology consultancy with more than 4,700 professionals across major talent hubs in Latin America, Spain and the U.S. The sellers are funds managed by Advent International, one of the largest and most experienced global private equity investors, and Cemex (CX) , a global construction materials company.

08:04 EDT Vivid Seats announces an exclusive multiyear media partnership with IAA - Vivid Seats announced an exclusive, multiyear media deal with I Am Athlete, IAA, the groundbreaking athlete-led media platform founded by former NFL All-Pro receiver Brandon Marshall. Launching with the official start of the 2024 NFL Season, the new strategic partnership includes exclusive content featuring athletes and celebrities, advertising and sponsorship rights, and live event experiences.

08:03 EDT Constellium announces results of ALIVE collaborative research project - Constellium announced the results of its collaborative research project ALuminium Intensive Vehicle Enclosures. Constellium's University Technology Center at Brunel University London was the lead partner of the project focused on developing structural aluminium battery enclosures for electric vehicles. The GBP 15m project, half funded by UK government subsidies through its Advanced Propulsion Center, began in 2020. The consortium, comprised of six industrial partners and two university technology partners, developed novel aluminium battery enclosure designs meeting challenging performance, manufacturing, weight, and cost targets for the project's OEM partners, BMW and Volvo. The project's multidisciplinary team investigated and implemented a wide range of joining and forming technologies in combination with Constellium's family of high-strength and high-crash alloys, Constellium HSA6 and Constellium HCA6, to create high-performance, lightweight, and cost-efficient aluminium designs. The project also enabled the creation of a full-scale battery enclosure prototyping line. Several different 1:1 scale prototypes have been built for a variety of vehicle platforms, passing a range of severe testing requirements such as side pole crash/side impact, bottom intrusion, acceleration, shock, vibration, and leak testing. The team also demonstrated the superior performance of coated aluminium solutions for fire resistance. The battery enclosure designs and associated manufacturing technologies developed as part of the ALIVE project enabled the team to save between 12% to 35% of the weight, depending on the design, compared to existing OEM aluminium and steel designs while meeting or exceeding performance targets. ALIVE also supported the development of cost models to quantify manufacturing costs and minimize capital expenditures to support future industrialization decision-making processes. Given the rapidly evolving EV market, the team had to adapt quickly and develop various technologies supporting OEMs' structural, non-structural, module-to-pack, and cell-to-pack battery enclosure strategies. Additionally, the consortium proposed a full cradle-to-grave Life Cycle Assessment validated by an external panel, demonstrating the benefit of aluminium solutions over ancillary steel designs.

08:02 EDT Stoke Therapeutics appoints Eric Olson Chief Business Officer. - Stoke Therapeutics announced the appointment of Eric Olson as Chief Business Officer. Mr. Olson has two decades of experience in life sciences business development and strategy with a track record of success, completing numerous transactions to maximize value for company pipelines across a variety of therapeutic areas, including rare genetic diseases, neurology and ophthalmology. In his new role, Mr. Olson will be responsible for leading and executing the Company's global corporate strategy and business development. "We see a significant opportunity to expand the potential of Stoke's first-in-class, disease-modifying approach to the treatment of many genetic diseases by upregulating protein expression with RNA based medicines," said Edward M. Kaye, M.D., Chief Executive Officer of Stoke Therapeutics. "Eric's deep experience leading global business development and corporate strategy teams, and in particular his most recent experience working for the foremost leader in RNA medicine, will make him instrumental in driving Stoke's next phase of growth. With Eric and other recent executive hires, we are building a world-class leadership team with the expertise and commitment to Stoke's mission of delivering new medicines to people living with severe diseases."

08:01 EDT Azenta appoints John Marotta as CEO - Azenta announced that John P. Marotta will join the Company as President and CEO effective September 9, succeeding Stephen Schwartz, who is retiring following a distinguished tenure. Schwartz will remain as an advisor to Azenta to ensure a smooth and successful transition. Marotta has two decades of experience leading global companies in life sciences, medical devices, and diagnostics, and is joining Azenta from Patient Square Capital, a leading healthcare investment firm, where he serves as Executive in Residence. Previously, he served as CEO and President of PHC Holdings Corporation, a diversified global life sciences, diagnostics, and medical device company focused on precision healthcare, growing global revenues and leading its IPO from owners KKR & Co. He also held a variety of senior executive roles in leading life sciences companies, including at Danaher Corporation, Envista Holdings Corporation, and Cardinal Health, Inc., where he demonstrated consistent achievement in organic revenue growth, operational efficiencies, and significant value-creating transactions. Mr. Marotta began his career in sales leadership roles for therapeutics and medical device offerings.

07:49 EDT Crescent Energy to acquire assets from private Eagle Ford operator for $168M - Crescent Energy announced the signing of a definitive agreement to acquire assets from a private Eagle Ford operator for total cash consideration of $168M, subject to customary purchase price adjustments. The acquisition is directly offset Crescent's existing Central Eagle Ford footprint and builds upon its significant acquisition activity in the Eagle Ford over the past 18 months, including the recently closed acquisition of SilverBow Resources. The transaction, which has an effective date of May 1, is expected to close in September, subject to customary closing conditions. The transaction is accretive to operating cash flow, levered free cash flow and net asset value per share, with unlevered cash-on-cash returns in excess of Crescent's 2.0x multiple on invested capital target.

07:47 EDT ANEW Medical announces goals for cell, gene therapy development - ANEW MEDICAL has two distinct goals for its pioneering cell and gene therapy development. One is to enhance the potential of people achieving a healthy long life, and the other is the development of effective treatments for age-related disorders and neurodegenerative diseases such as ALS, Alzheimer's and Parkinson's disease. ANEW has secured exclusive worldwide rights and issued patents in the USA, Canada, Europe, Hong Kong and China, covering the secreted form of Klotho, known scientifically as s-KL. Klotho is often referred to as "the anti-aging gene." It is named after the Greek goddess who is said to spin the thread of life. Existing data supports ANEW's scientific hypothesis that maintaining high levels of Klotho as we age leads to a long and healthy life whereas depleted levels of Klotho may lead to neurodegenerative diseases such as ALS, Alzheimer's and Parkinson's Diseases as well as other age-related disorders including cardiovascular conditions, osteoporosis, and the muscle-wasting disorder, sarcopenia. ANEW hopes to further demonstrate the validity of its hypothesis by examining the stored blood samples of a cohort of people who stayed healthy and reached very old age, many in excess of 100 years, in Okinawa, Japan. Okinawa is one of the famous "Blue Zones" of the world. The results of this study will be compared to a matching cohort of an aging population who have experienced neurodegenerative diseases such as ALS, Alzheimer's, Parkinson's and other age-related disorders. ANEW is focused on both enhancing the potential for people to experience healthy longevity as well as on the development of cell and gene-based therapies to treat neurodegenerative and age-related disorders based on its patented Klotho technology. The company hopes to obtain FDA agreement in the near future to enter the clinic in at least one indication area. It has also recently announced a partnership with the key scientists involved in the Okinawa Centenarian Research Center for Longevity who are retained as Advisor on longevity and the development of new pharmaceutical treatments. This includes Drs. Craig and Bradley Willcox, authors of the best-selling, Oprah Winfrey recommended, book, "The Okinawa Program: How the World's Longest-Lived People Achieve Everlasting Health-And How You Can Too."

07:46 EDT Tenon Medical announces publication of Catamaran SI Joint Fusion System study - Tenon Medical announced the first publication of the Catamaran SI Joint Fusion System MAINSAIL study. This study is an ongoing prospective, single-arm, multi-center, post-market study evaluating clinical and radiographic outcomes of adult patients with sacroiliac joint disruptions or degenerative sacroiliitis treated with the Catamaran SI Joint Fusion System. The target enrollment for this study is up to 50 patients with up to 24-month follow-up. This interim analysis presents early experiences of the first 33 consecutive patients treated with the Catamaran SI Joint Fusion System across six US clinical sites, with primary and secondary clinical endpoint analysis at 6 months and radiographic CT fusion assessment, performed by an independent radiologist. Notable outcomes from this interim analysis include the following: Statistically Significant Reduction in SIJ Pain and Disability Scoring at 6 months: Mean VAS SIJ pain intensity scores significantly decreased from pre-operative levels of 80.9mm to 31.1mm; ODI scores, measuring a patient's perceived disability, showed a significant improvement from pre-operative values of 51.9% to 29.6%; 66.6% of subjects demonstrated an improvement in ODI by more than 15%. Robust Safety Profile: No serious adverse events, no reoperations, and no reinterventions reported. No vascular or nerve injuries associated with the use of the inferior-posterior surgical approach used to deliver the Catamaran implant. High Patient Satisfaction Throughout All Follow-Up Timepoints: 93.3% of patients reported high satisfaction with their treatment at 6 months. Definitive Evidence of Fusion Response at 12 months: 6 patients have reached 12 months follow-up with CT radiographic imaging. 4 of the 6 patients showed unequivocal evidence of fusion with bridging bone as identified by an independent radiology reviewer. Efficient Surgical Technique and Procedural Workflow: 55% of procedures were completed in under 45 minutes, with the shortest procedural time recorded as 24 minutes. 50% of procedures utilized less than 1 minute of fluoroscopy time. All procedures were performed in an outpatient setting. The Catamaran SI Joint Fixation device is a single robust titanium implant comprised of two pontoons, connected by an osteotome bridge, which is designed to transfix the SI joint along its longitudinal axis providing immediate fixation and stabilization of the joint, with the aim of achieving a successful long-term fusion. The Catamaran implant was developed with respect to AO principles of arthrodesis including adequate joint preparation, rigid fixation and stabilization, and 3) adequate bone graft augmentation. Via a minimally invasive inferior-posterior approach the Catamaran implant is delivered within the dense cortical bone of the sacrum and ilium, to transfix and stabilize the SI joint for the treatment of SIJ dysfunction. To date, there have been 700 Catamaran fixation devices implanted to treat primary SI Joint dysfunction and sacroiliitis, as well as revise previously treated SI joints with failed alterative SI joint implants. These interim outcomes from the MAINSAIL study provide early evidence of the clinical safety and efficacy of the Catamaran SI Joint Fusion System as a promising minimally invasive treatment option for patients suffering from painful SI joint dysfunction. The Catamaran MAINSAIL study is on-going and further analysis will be performed upon study completion up to 24-month follow-up.

07:45 EDT Lyft confirms no changes to Q3, FY24 guidance

07:43 EDT Telomir Pharmaceuticals appoints Itzchak Angel as chief scientific advisor - Telomir Pharmaceuticals announced the appointment of Dr. Itzchak Angel as Chief Scientific Advisor. Dr. Angel, in collaboration with Telomir's senior management, will look to expedite the pre-clinical and clinical path of Telomir's lead product candidate, Telomir-1, a novel small molecule designed to lengthen the DNA's protective telomere caps, which are crucial in the aging process. Dr. Angel was previously the Head of Pharmacology at Synthelabo.

07:43 EDT Lyft announces restructuring plan related to bikes, scooters transportation mode

07:40 EDT Psyence Biomedical enters exclusive licensing agreement with PsyLabs - Psyence Biomedical announced that the Company has entered into a worldwide, exclusive royalty-bearing IP licensing agreement with PsyLabs. Pursuant to this licensing agreement, PsyLabs will supply Psyence Biomed with pharmaceutical-grade, EU GMP nature-derived psilocybin to be evaluated in future clinical trials as a potential treatment for AUD and other SUDs, and for commercialization of the licensed product. Psyence Biomed plans to lead with a clinical trial in AUD, Psyence Biomed's second development indication. The licensed product will require further development work by PsyLabs, which will be conducted during the remainder of 2024 and into 2025. Development of Psyence Biomed's first indication is planned to commence with a Phase IIb trial to evaluate nature-derived psilocybin in Adjustment Disorder in patients who have had an advanced cancer diagnosis in the Palliative Care context.

07:39 EDT SelectQuote unit SelectRx to open 3rd fulfillment facility in Olathe, Kansas - SelectQuote announced that SelectRx, the company's full-service medication management pharmacy that serves all 50 states, will open a third fulfillment facility in Olathe, Kansas, to serve its rapidly expanding customer base, alongside its existing facilities in Monaca, Pennsylvania, and Indianapolis, Indiana. SelectQuote launched the SelectRx business in 2021 as part of its Healthcare Services Division after acquiring two smaller pharmacy operations. In just over three years, SelectRx has grown its membership from under 5,000 to over 75,000 members who receive regular prescription shipments in adherence-friendly packaging. The new 54,000 square foot state-of-the-art facility at 404 W. Frontier Lane in Olathe, Kansas, is expected to open during the first half of calendar 2025 and should significantly expand the pharmacy's capacity.

07:39 EDT Safe Harbor Financial announces executive contract extensions - SHF Holdings d/b/a/ Safe Harbor Financial announced extensions to the contracts of three key executives and a restructuring of their compensation packages. The restructured agreements include Sundie Seefried, President / CEO, extended for one year through September 2025; Dan Roda, extended through June 30, 2025; and Tyler Beuerlein, whose term remains unchanged, continuing through February 2025. Beuerlein serves as the company's Chief Strategic Business Development Officer; Roda transitions into the newly created role of Chief Credit Officer, focusing on the company's lending and loan participation business lines. As part of the restructuring, the Company will realize an initial cost savings of $350,000 as the new compensation structure reduces base pay in favor of incentives aligned more closely with company revenue and growth objectives.

07:36 EDT Biogen announces higher dose of nusinersen shows statistical improvement - Biogen announced positive, topline data from the pivotal cohort of the Phase 2/3 DEVOTE study evaluating the safety and efficacy of a higher dose regimen of nusinersen in treatment-naive, symptomatic infants with spinal muscular atrophy, SMA. The investigational higher dose regimen of nusinersen comprises a more rapid loading regimen, two 50 mg doses 14 days apart, and a higher maintenance regimen, 28 mg, every 4 months, compared to the approved nusinersen regimen, SPINRAZA. The study met its primary endpoint at six months, achieving a statistically significant improvement in motor function in infants who received the higher dose regimen as compared to a prespecified matched sham control group from the ENDEAR study. The higher dose cohort showed statistically significant improvement over the matched sham comparator on the primary endpoint of change in CHOP-INTEND from baseline to six months. Results favored the higher dose regimen relative to sham across secondary endpoints and trended in favor of the higher dose regimen over the currently approved 12mg regimen on key biomarker and efficacy measures. The higher dose regimen was generally well tolerated, with reported adverse events generally consistent with SMA and the known safety profile of nusinersen.

07:32 EDT CME Group reports August ADV of 31.7M contracts - CME Group reported its second-highest monthly volume ever, with average daily volume, or ADV, up 31% to 31.7 million contracts in August, driven by double-digit increases across all six asset classes. The company's interest rate ADV reached a record 18.3M contracts and its deeply liquid U.S. Treasury complex hit an all-time monthly record ADV of 11.5M contracts, including the highest volume ever for 2-year, 5-year and 30-year futures contracts. In addition, SOFR futures and options volume climbed 48% to 6.3M contracts and the company's BrokerTec cash U.S. Treasury notional volume hit a year-to-date record of $249B on August 5.

07:17 EDT Aya Gold & Silver announces drill results from program at Zgounder Silver Mine - Aya Gold & Silver reported additional high-grade silver drill results from its at-depth drill exploration program at the Zgounder Silver Mine in the Kingdom of Morocco. Highlights: In the Central Zone from the 1,950m level: hole DZG-SF-24-081 intercepted 1,339 grams per tonne silver over 9.5 meters, including 2,984 g/t Ag over 4.0m; hole DZG-SF-24-089 intercepted 2,522 g/t Ag over 3.0m, including 7,052 g/t Ag over 1.0m; hole DZG-SF-24-134 intercepted 448 g/t Ag over 10.5m. In the Western Zone from the 2,000m level: hole ZG-SF-24-141 intercepted 626 g/t Ag over 6.0m; hole ZG-SF-24-163 intercepted 536 g/t Ag over 7.0m. In the Eastern Zone from the 2,000m level: hole DZG-SF-24-111 intercepted 2,372 g/t Ag over 6.5m; and 1,042 g/t Ag over 4.5m; hole DZG-SF-24-098 intercepted 1,244 g/t Ag over 4.0m, including 2,242 g/t Ag over 2.0m; hole DZG-SF-24-108 intercepted 747 g/t Ag over 6.0m. Exploration holes near the granite contact: hole ZG-SF-24-183 intercepted 376 g/t Ag over 9.3m; hole DZG-SF-24-164 intercepted 657 g/t Ag over 10.5m, including 1,037 g/t Ag over 4.5m; 21,190m of the 2024 exploration program drilled year to date. "Today's high-grade drill results including hole DZG-SF-24-111continue to confirm high-grade continuity of silver mineralization at Zgounder," said Benoit La Salle, CEO. "In addition, the silver-rich intercepts in the western and eastern extremities continue to increase the resource expansion potential. We currently have four underground rigs turning that will deliver additional results in the coming months."

07:14 EDT Blue Biofuels receives $1.15M Department of Energy Phase 2 grant - Blue Biofuels announces that it has been awarded a Phase 2 Small Business Innovation Research, SBIR, grant from the U.S. Department of Energy amounting to $1.15 million. This significant funding will support the final stages of scaling the company's patented Cellulose-to-Sugar process, a groundbreaking technology that efficiently converts plant-based cellulose into sugars, which are fermented into ethanol to be used as sustainable biofuels. This Phase 2 grant follows the successful completion of Phase 1, where Blue Biofuels demonstrated the feasibility and effectiveness of its CTS process, paving the way for this Phase 2 grant.

07:13 EDT Enstar Group announces expiration of 'go-shop' period - Enstar Group announced the expiration of the 35-day "go-shop" period as provided in the previously announced definitive merger agreement, pursuant to which Sixth Street will acquire Enstar for $5.1 billion. The go-shop period expired at 11:59 p.m. ET on September 2, 2024. During the "go-shop" period, Enstar, with the assistance of its financial advisor Goldman Sachs & Co. LLC, actively solicited alternative acquisition proposals from 34 potentially interested third parties. To date, the Company has not received any additional acquisition proposals following the execution of the merger agreement. As the "go-shop" period has ended, Enstar and its financial advisor have now entered into the "no-shop" period. During the "no-shop" period, the Company will be subject to customary restrictions limiting its ability to solicit any alternative acquisition proposals and to participate in discussions or negotiations with or provide non-public information to any person relating to any acquisition proposal, subject to customary "fiduciary out" provisions. The transaction, which has been unanimously approved and recommended to its shareholders by Enstar's Board of Directors, is expected to close in mid-2025, subject to approval by Enstar's shareholders, regulatory approvals, and other customary closing conditions. Upon completion of the transaction, Enstar will become a privately-held company.

07:12 EDT BioCryst reports inducement grants under Nasdaq listing rule - BioCryst Pharmaceuticals announced that the compensation committee of BioCryst's board of directors granted nine newly-hired employees stock options to purchase an aggregate of 28,400 shares, and restricted stock units covering an aggregate of 20,025 shares, of BioCryst common stock. The options and RSUs were granted as of August 30, 2024, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $8.69 per share, which is equal to the closing price of BioCryst common stock on the grant date. The options and RSUs vest in four equal annual installments beginning on the one-year anniversary of the grant date, in each case subject to the new employee's continued service with the company. Each stock option has a 10-year term. The options and RSUs are subject to the terms and conditions of BioCryst's Inducement Equity Incentive Plan and a stock option agreement or restricted stock unit agreement, as applicable, covering the grant.

07:10 EDT Ciena CFO Moylan plans to retires in one year, effective August 28 - Ciena announced that James E. Moylan, Jr., Senior Vice President and Chief Financial Officer CFO , plans to retire in twelve months, effective August 28 . Ciena intends to commence a search process to identify a successor. Mr. Moylan will continue to serve as CFO until a successor is in place and he will assist in the transition of his responsibilities. "Jim has given more than 16 years of dedicated and distinguished service to Ciena. He has been a key member of our executive team and has played a significant role in the growth of our business and the strength of our operating model," said Gary Smith, president and CEO, Ciena.

07:08 EDT Cyngn granted patent for method to preserve data from autonomous vehicles - Cyngn announced the official granting of a new patent, U.S. Patent No. 12,032,099, which introduces a method to maintain the accuracy of data collected by an autonomous vehicle's sensors as the vehicle moves. Since August 2023, Cyngn has been granted ten additional patents, bringing the total U.S. patents granted to 20. Patent 20 protects systems that improve the ability of Cyngn's autonomous vehicles to make intelligent decisions about its environment. At its core, the patent optimizes sensor data processing by integrating advanced LiDAR and image technologies. By initially capturing comprehensive environmental data, the system then calculates and adjusts for any time delay between data acquisition and processing. Crucially, it dynamically generates a motion model based on real-time sensor movements across multiple axes, ensuring precise predictions of future positions. The significance of this patent lies in its ability to significantly enhance the reliability and precision of sensor data in autonomous vehicles and robotics by effectively compensating for motion during data processing.

07:06 EDT Eledon Pharmaceuticals completes enrollment for Phase 2 BESTOW trial - Eledon Pharmaceuticals announced that it has successfully completed enrollment for its Phase 2 BESTOW clinical trial, which is designed to assess the safety and efficacy of its investigational immunosuppression therapy tegoprubart for the prevention of organ rejection in patients undergoing kidney transplantation. The trial reached its target enrollment of 120 participants approximately four months earlier than originally planned.

07:05 EDT Dick's Sporting backs FY24 CapEx ~$900M on gross basis; ~$800M on net basis

07:05 EDT Alta Equipment Group appoints Colin Wilson to board of directors - On September 1, 2024, the Board of Directors of Alta Equipment Group elected Colin Wilson to join the Board of the Company, effective immediately, filling a vacancy. Mr. Wilson was elected to the class of directors whose term expires at the Company's annual meeting of shareholders in 2026. Wilson held the President and CEO role at Hyster-Yale Group until January 2020, when he retired.

07:04 EDT Dick's Sporting CEO says 'we delivered a very strong second quarter' - Lauren Hobart, President and CEO said, "We delivered a very strong second quarter. Powered by our compelling omni-channel athlete experience, differentiated product assortment, best-in-class teammate experience and our ability to create deep engagement with the DICK'S brand, we are driving sustained top-line momentum and gaining market share. Our Q2 comps were driven by growth in average ticket and transactions, and with growth in sales, gross margin expansion and SG&A leverage, we delivered EBT margin of nearly 14%. Because of our strong Q2 performance and the confidence we have in our business, we are again raising our full year outlook." Ed Stack, Executive Chairman said, "Our strong second quarter demonstrated the continued success of our long-term strategies and how DICK'S is truly differentiated within the industry. We are very enthusiastic about the significant growth opportunities ahead of us, including House of Sport and the repositioning of our portfolio. The future of our business is very bright, and I'd like to thank all our teammates for their strong execution in Q2 and for their dedication to DICK'S Sporting Goods."

07:03 EDT Axsome Therapeutics announces FDA acceptance of NDA resubmission for AXS-07 - Axsome Therapeutics announced that the U.S. Food and Drug Administration, FDA, has acknowledged the resubmission of the Company's New Drug Application, NDA, for AXS-07 for the acute treatment of migraine. The FDA designated the resubmission as a Class 2 resubmission and set a Prescription Drug User Fee Act, PDUFA, action goal date of January 31, 2025.

06:42 EDT Dollar Tree falls 13% to $71.11 after Q2 results miss, FY24 guidance cut

06:41 EDT Quarterhill iTHEIA AI Video ATR selected by Minnesota DOT - Quarterhill announced the award of a contract for the supply of iTHEIA AI Video Automatic Traffic Recorders, or ATR, for Minnesota DOT.

06:35 EDT Dollar Tree provides update on store portfolio optimization review - "During the fourth quarter of fiscal 2023, we announced that we had initiated a comprehensive store portfolio optimization review which involved identifying stores for closure, relocation or re-bannering based on an evaluation of current market conditions and individual store performance, among other factors. As a result of the portfolio optimization review, we identified approximately 970 underperforming Family Dollar stores, including approximately 600 stores to be closed in the first half of fiscal 2024, and approximately 370 stores to be closed at the end of each store's current lease term. As of August 3, 2024, we have closed approximately 655 stores identified under the portfolio optimization review and expect to close an additional 45 during the remainder of fiscal 2024."

06:33 EDT Roche to present data for fenebrutinib from Phase II FENopta OLE study - Roche will present new 48-week data for the investigational Bruton's tyrosine kinase, BTK, inhibitor fenebrutinib from the Phase II FENopta open-label extension, OLE, study at the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, ECTRIMS, in Copenhagen, Denmark on 18 September 2024. Results demonstrate that patients with relapsing multiple sclerosis, RMS, treated with fenebrutinib for up to one year maintained very low levels of disease activity and no disability progression. During the OLE period, 96% of patients treated with fenebrutinib were free of relapses at one year, with an annualised relapse rate of 0.04, and no change in disability over 48 weeks as measured by the Expanded Disability Status Scale. Fenebrutinib treatment suppressed disease activity in the brain as measured by MRI scans. At 48 weeks, 99% of patients were free of T1 gadolinium-enhancing lesions, markers of active inflammation. Over the 48 weeks of OLE with continued fenebrutinib treatment, there was three times more reduction in the volume of T2 lesions, which represent chronic disease burden, compared to the end of the double-blind period. The safety profile of fenebrutinib in the OLE was consistent with previously reported data. The most common adverse events in greater than5% of patients were urinary tract infection, COVID-1 and pharyngitis. Serious AEs occurred in one patient.

06:21 EDT Waterdrop announces 2c per share special cash dividend - The board has approved a special cash dividend of 2c per ADS to shareholders of record as of the close of business on October 11. The payment date is expected to be on or around November 5 for holders of ordinary shares and on or around November 8 for holders of ADSs.

06:12 EDT Quhuo International, Get Holdings establish pact in Azerbaijan with Volt Auto - Quhuo International, the overseas division of Quhuo, and Get Holdings established a strategic partnership in Azerbaijan with electric vehicle, or EV, dealer Volt Auto and mobility platform Bolt. This strategic partnership aims to boost EV adoption, improve ride-hailing services, and enhance local lifestyle services, marking a key step in Quhuo International's global strategy.

06:03 EDT Digihost provides Bitcoin production results for August - Digihost Technology is pleased to provide unaudited comparative Bitcoin production results for the month ended August 31, 2024, combined with an operations update. All monetary references are expressed in USD unless otherwise indicated. Monthly Production Highlights for August 2024: The company held cash, BTC and cash deposits of approximately $10.4M as of August 31, 2024 (based on a BTC price of $58,970 as of August 31, 2024 per CoinMarketCap), as compared to $6.9M as of July 31, 2024 (based on a BTC price of $65,100 as of July 31, 2024 per CoinMarketCap). Between self-mining and hosting agreements, miners at the company's facilities produced approximately 55 BTC during the month of August, representing an increase of approximately 30% as compared to July 2024. As previously disclosed in its news release of June 11, 2024, Digihost entered into a new agreement pursuant to which the company will integrate 11,000 state-of-the-art S21 miners into its facilities, translating to approximately 44MW of shared revenues. The deployment of those next-generation, energy-efficient miners has commenced and will be completed in phases, and the company is targeting to be at a total of 3.2 EH/s by the end of September 2024. The company spent approximately $0.8M on capital expenditures, mining infrastructure support equipment, and deposits. Digihost continues to monitor its capital expenditures closely, using self-funding to limit equity dilution for its shareholders when viable. Presently, Digihost's consolidated operating capacity across its three sites represents approximately 90MW of available power, and Digihost is mining at hashrate of 2.75 EH/s. The company is currently exploring opportunities to build its initial Tier 3 data center with a target completion date of end of 2025.

05:51 EDT Blackstone to acquire AirTrunk in A$24B transaction - Funds managed by Blackstone, along with the Canada Pension Plan Investment Board, or CPP Investments, have entered into a definitive agreement to acquire AirTrunk, the Asia Pacific data center platform, from Macquarie Asset Management and the Public Sector Pension Investment Board, for an implied enterprise value of over A$24B. This represents Blackstone's largest investment in the Asia Pacific region. The transaction is subject to approval from the Australian Foreign Investment Review Board. AirTrunk is the largest data center platform in the Asia Pacific region, with a sizeable presence in Australia, Japan, Malaysia, Hong Kong, and Singapore. It has more than 800MW of capacity committed to customers and owns land that can support over 1GW of future growth across the region.

05:35 EDT Autohome announces new $200M share repurchase program - Autohome announced that its board of directors has approved a new share repurchase program, effective from September 4. Pursuant to the new share repurchase program, the company may repurchase up to $200M worth of its shares over the next 12 months.

05:23 EDT Indivior provides update on AEF01171 trial, does not expect to exercise option - Indivior is providing an update following Aelis Farma's announcement of the results from its clinical Phase 2B trial with AEF01171, evaluating the efficacy and safety in treatment-seeking participants with moderate to severe Cannabis Use Disorder, or CUD. The purpose of this trial was twofold: to show that AEF0117 lowers cannabis use and to determine the endpoints and optimal dosage of AEF0117 for use in future studies. In this phase 2B study, patients were treatment-seeking participants, 84% of whom had severe CUD. The results of the study demonstrated that the primary endpoint, the proportion of participants who reduced their cannabis use to one day per week, as well as secondary endpoints measuring the proportion of participants reaching either complete abstinence or who used two days per week, were not met. Although these results are disappointing, they indicate that significant work remains to be done to understand subpopulations of patients with CUD, specifically those with severe CUD. This clinical Phase 2B study is part of the strategic collaboration between Aelis Farma and Indivior, which includes an exclusive option for Indivior to license the global rights to AEF0117. Given the lack of separation from placebo on primary and secondary endpoints and before seeing further additional clinical data, Indivior does not currently expect to exercise its option.

05:12 EDT WiSA Technologies to acquire assets, IP from Datavault in $210M transaction - WiSA Technologies announced that it has executed a definitive asset purchase agreement to purchase the Datavault intellectual property and information technology assets of privately held Data Vault Holdings for $210M, consisting of 40M shares of common stock of WiSA Technologies to be issued at $5 per share plus a $10M three-year note. Closing, subject to customary conditions and approval by the stockholders of WiSA Technologies, is expected to occur prior to December 31. The management teams of WiSA Technologies and Data Vault Holdings will host an investor conference call to discuss the transaction. The resulting publicly traded data technology and licensing company will enable clients and strategic partners to monetize their Blockchain Data and AI Web 3.0 assets via tokenization, data ownership and digital twins. Following the asset acquisition, the company will include the Datavault and ADIO assets, talent and experience with WiSA Technologies to offer two solutions. Data Sciences will license high performance computing, or HPC, software applications and Web 3.0 data management serving biotech research, energy, education, fintech, real estate, healthcare, among others. Acoustic Sciences will license spatial and multichannel HD sound transmission, including Adio, WiSA and Sumerian, to customers in sports & entertainment, events & venues, restaurants, automotive, finance, and other industries. The $210M consideration will be paid to Data Vault in exchange for Datavault and Adio intellectual property and information technology assets by WiSA Technologies. A total of $200M will be in the form of shares of restricted common stock of WiSA Technologies to be issued at $5.00 per share, $10M will be paid in an unsecured promissory note due three years from closing, with 10% of the proceeds of any financings used to pay down or pay off the promissory note in the interim. And lastly, a 3% royalty on future revenues from Datavault and ADIO product lines will be paid to Master Vault. Closing is subject to customary conditions and approval by the stockholders of WiSA Technologies. The proxy is expected to be mailed around the end of September, with the stockholders meeting to be held in Q4. Upon closing, Nathaniel Bradley, CEO and co-founder of Data Vault, will become CEO and Brett Moyer, CEO of WiSA, will become CFO. The company intends to change its name to Datavault Inc.